Personality disorders, excluding more controls

KRA_PSY_PERSON_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F60, F61 Hospital discharge: ICD-9 — 31[0\|2\|4]\|315A\|31[6-8] Hospital discharge: ICD-8 — 30100\|301[2-9] Cause of death: ICD-10 — F60, F61 Cause of death: ICD-9 — 31[0\|2\|4]\|315A\|31[6-8] Cause of death: ICD-8 — 30100\|301[2-9] 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_PERSON_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F6[0-1]
HD_ICD_9	31[0\|2\|4]\|315A\|31[6-8]
HD_ICD_8	30100\|301[2-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F6[0-1]
COD_ICD_9	31[0\|2\|4]\|315A\|31[6-8]
COD_ICD_8	30100\|301[2-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Personality disorders, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	118192	61352	55922
Only index persons	104272	56926	47346
Unadjusted period prevalence (%)
Whole population	1.66	1.76	1.56
Only index persons	1.96	2.09	1.81
Median age at first event (years)
Whole population	31.56	32.06	30.92
Only index persons	30.95	31.47	30.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13651	8841	4810
Unadjusted period prevalence (%)	2.81	3.14	2.21
Median age at first event (years)	33.23	32.57	34.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14221: Matched controls
141860

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05AX15

ATC

cariprazine; oral

1654.3

323.3

314

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

6.2

323.3

567

946

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

322.7

3121

15557

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

99.1

321.6

167

EBA30

NOMESCO Finland

Extraction of root of tooth

4.0

320.4

951

2476

H03AA01

ATC

levothyroxine sodium; systemic

2.2

320.3

3305

16914

IGY99, ,

SPAT

5.6

320.2

627

1162

SPAT1310

SPAT

Counselling related to known health issue

2.1

319.8

4648

27129

IAB11

NOMESCO Finland

Psychiatric mood consultation

109.6

317.3

163

Z72.0

ICD-10 Finland

Tobacco use

5.8

317.1

594

1056

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

16.8

315.2

264

160

N17

ICPC

Vertigo/dizziness

2.8

314.7

1820

7133

R05

ICPC

Cough

2.1

314.6

3963

21911

R52.9

ICD-10 Finland

Pain, unspecified

2.8

314.4

1788

6947

N03AF02

ATC

oxcarbazepine; oral

5.3

314.3

655

1284

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

312.3

299

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

6.0

311.7

559

953

G44.2

ICD-10 Finland

Tension-type headache

2.5

311.2

2410

10884

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

11.1

309.2

331

305

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

+∞

309.2

296

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

308.1

295

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

307.7

437

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

156.0

307.7

276

F39

ICD-10 Finland

Unspecified mood [affective] disorder

50.8

307.7

1153

246

F60.8

ICD-10 Finland

Other specific personality disorders

524.1

307.7

1114

N06AX11

ATC

mirtazapine; oral

9.1

307.7

8721

21018

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1401.3

307.7

1162

R51.80

ICD-10 Finland

Headache

2.8

307.7

3237

13315

SPAT1265

SPAT

Breathalyser

33.4

307.7

340

104

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

221.1

307.7

1327

L28

ICPC

Limited function/disability (L)

3.2

307.7

2366

8307

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

307.7

339

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

3131.3

307.7

317

F34.0

ICD-10 Finland

Cyclothymia

86.4

307.7

230

F61

ICD-10 Finland

Mixed and other personality disorders

260.8

307.7

720

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

8.4

307.7

1643

2174

F50.1

ICD-10 Finland

Atypical anorexia nervosa

109.6

307.7

280

IFA99, ,

SPAT

58.7

307.7

203

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

887.4

307.7

2120

SPAT1307

SPAT

Psychosocial counselling and guidance

5.9

307.7

2133

4095

F51.0

ICD-10 Finland

Nonorganic insomnia

3.4

307.7

3803

13647

A10BA02

ATC

metformin; oral

2.4

307.7

3492

17121

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

307.7

4943

25794

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

4.6

307.7

1097

2511

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

79.4

307.7

235

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

31.2

307.7

543

180

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

3287.5

307.7

332

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

+∞

307.7

334

N06AX05

ATC

trazodone; oral

39.8

307.7

1221

334

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1415.3

307.7

1052

N05AN01

ATC

lithium; oral

356.8

307.7

1701

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

76.7

307.7

2923

477

SPAT1260

SPAT

Consultation of another employee

2.6

307.7

2672

11760

N03AX11

ATC

topiramate; oral

7.9

307.7

786

1041

P73

ICPC

Affective psychosis

277.6

307.7

273

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

11.3

307.7

1614

1587

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

286.6

307.7

364

N05CF01

ATC

zopiclone; oral

6.3

307.7

6635

17206

N05AA01

ATC

chlorpromazine; systemic, rectal

403.4

307.7

729

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.1

307.7

1907

6809

EBA15

NOMESCO Finland

Extraction of multiple teeth

6.0

307.7

675

1159

N06AX22

ATC

agomelatine; oral

27.3

307.7

1103

435

N01

ICPC

Headache

2.8

307.7

2652

10786

N06AB04

ATC

citalopram; systemic

13.5

307.7

6542

8409

N05BA12

ATC

alprazolam; oral

9.3

307.7

2805

3643

R4140

NOMESCO Finland

Psychotherapy

72.0

307.7

269

F22.0

ICD-10 Finland

Delusional disorder

508.0

307.7

539

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

649.7

307.7

4992

118

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

197.8

307.7

234

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3680.3

307.7

722

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

416.2

307.7

368

N05AD03

ATC

melperone; systemic

128.1

307.7

472

SPAT1227

SPAT

Substance abuse rehabilitation

36.5

307.7

241

N06BA12

ATC

lisdexamfetamine; oral

22.1

307.7

467

218

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

43.0

307.7

225

R41.0

ICD-10 Finland

Disorientation, unspecified

10.3

307.7

366

362

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

60.9

307.7

432

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

10.7

307.7

423

404

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2349.6

307.7

1751

F50.9

ICD-10 Finland

Eating disorder, unspecified

88.6

307.7

612

F41.3

ICD-10 Finland

Other mixed anxiety disorders

12.1

307.7

640

552

A04

ICPC

Weakness/tiredness general

3.2

307.7

3052

11236

N04AA02

ATC

biperiden; systemic

198.5

307.7

982

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

307.7

775

A29

ICPC

General symptom/complaint other

3.0

307.7

2118

7816

SPAT1241

SPAT

Extensive assessment of psychosocial situation

13.1

307.7

433

340

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

307.7

3898

18693

N05BE01

ATC

buspirone; oral

64.5

307.7

1761

310

P98

ICPC

Psychosis NOS/other

670.3

307.7

329

ZXY60

NOMESCO Finland

2-person team, nurses

476.7

307.7

374

Z29

ICPC

Social problem NOS

7.6

307.7

586

793

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

5.9

307.7

1261

2307

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

95.5

307.7

1407

163

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

1825.5

307.7

341

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

5948

34742

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.1

307.7

7677

50579

N03AX12

ATC

[U] gabapentin; oral

3.7

307.7

2761

8623

ZY000

NOMESCO Finland

Hospital inpatient

156.7

307.7

815

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

250.4

307.7

1741

M54.5

ICD-10 Finland

Low back pain

2.1

307.7

5944

36317

L03

ICPC

Low back symptom/complaint

2.3

307.7

4947

27104

N02BF02

ATC

pregabalin; oral

5.1

307.7

1534

3308

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

26.1

307.7

534

212

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

19.4

307.7

702

379

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4911.0

307.7

486

N05AA02

ATC

levomepromazine; systemic

223.5

307.7

2765

153

N06AB06

ATC

sertraline; oral

18.1

307.7

5003

4122

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

70.6

307.7

352

L17

ICPC

Foot/toe symptom/complaint

2.5

307.7

4983

25124

R52.2

ICD-10 Finland

Other chronic pain

5.8

307.7

785

1404

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

52.6

307.7

274

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.9

307.7

1959

5574

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

278.1

307.7

1106

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

307.7

332

N03AX09

ATC

lamotrigine; oral

52.4

307.7

3513

882

F41.00

ICD-10 Finland

Moderate panic disorder

80.8

307.7

803

105

F21

ICD-10 Finland

Schizotypal disorder

4506.9

307.7

448

B18.2

ICD-10 Finland

Chronic viral hepatitis C

51.6

307.7

690

140

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

9.4

307.7

1685

1999

ZYC01

NOMESCO Finland

Remote contact by phone

7.2

307.7

1811

2800

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2385.7

307.7

3712

F60.9

ICD-10 Finland

Personality disorder, unspecified

1233.1

307.7

2539

SPAT1254

SPAT

Administration of medicine

3.2

307.7

2363

8342

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

307.7

518

F31

ICD-10 Finland

Bipolar affective disorder

317.3

307.7

810

A06AD11

ATC

lactulose; oral

5.0

307.7

2217

5060

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

323.0

307.7

560

P18

ICPC

Medication abuse

189.1

307.7

423

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

9.1

307.7

652

748

K02.1

ICD-10 Finland

Caries of dentine

2.1

307.7

9835

73005

OAB43, ,

SPAT

0.4

307.7

2700

53328

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.1

307.7

8781

61615

F33.8

ICD-10 Finland

Other recurrent depressive disorders

67.6

307.7

535

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

370.5

307.7

1406

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

307.7

1060

S10

ICPC

Boil/carbuncle

3.7

307.7

1166

3372

P06

ICPC

Sleep disturbance

3.7

307.7

2989

9418

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

91.6

307.7

279

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

104.2

307.7

396

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

44.3

307.7

1190

292

Z3226

NOMESCO Finland

Physiotherapist

2.9

307.7

2749

10741

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

154.9

307.7

184

N05BA05

ATC

potassium clorazepate; oral

27.4

307.7

227

AA1AD

NOMESCO Finland

CT of head and brain

3.3

307.7

3976

14769

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

307.7

1729

5216

N03AX16

ATC

[U] pregabalin

4.1

307.7

4239

13242

M79.6

ICD-10 Finland

Pain in limb

2.0

307.7

6683

43061

P01

ICPC

Feeling anxious/nervous/tense

5.8

307.7

4650

10969

R06.0

ICD-10 Finland

Dyspnoea

2.6

307.7

3875

17996

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2231.4

307.7

1485

N05AF01

ATC

flupentixol; systemic

45.0

307.7

630

146

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

307.7

431

A28

ICPC

Limited function/disability NOS

4.3

307.7

1982

5165

F32.1

ICD-10 Finland

Moderate depressive episode

8.0

307.7

2047

2931

F61.0

ICD-10 Finland

Mixed personality disorders

999.3

307.7

3307

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

805.9

307.7

1952

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

307.7

3162

15155

F60.2

ICD-10 Finland

Dissocial personality disorder

1642.5

307.7

464

P72

ICPC

Schizophrenia

515.8

307.7

919

F41.1

ICD-10 Finland

Generalized anxiety disorder

16.3

307.7

2626

1946

IBA03

NOMESCO Finland

Psychotherapy evaluation

335.6

307.7

456

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.2

307.7

4113

22077

N05AH02

ATC

clozapine; systemic

5937.5

307.7

1120

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

381.3

307.7

1255

N05CF02

ATC

zolpidem; oral

4.1

307.7

3590

10848

P17

ICPC

Tobacco abuse

8.9

307.7

412

472

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

307.7

553

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

1418.3

307.7

543

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.5

307.7

1363

2688

F90.0

ICD-10 Finland

Disturbance of activity and attention

15.7

307.7

1724

1239

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.5

307.7

1063

2519

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

307.7

990

IHZ04, ,

SPAT

13.8

307.7

690

521

F10.09

ICD-10 Finland

Alcohol intoxication UNS

299.5

307.7

794

SPAT1216

SPAT

Assessment of functional ability

3.0

307.7

1651

5879

IGV01

NOMESCO Finland

Psychiatric network contact

2458.1

307.7

733

N06AB10

ATC

escitalopram; oral

8.2

307.7

6302

12583

N05AX08

ATC

risperidone; systemic

141.9

307.7

3909

378

X78

ICD-10 Finland

Intentional self-harm by sharp object

4602.4

307.7

457

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.4

307.7

1238

3034

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

307.7

3638

17530

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.2

307.7

5235

30032

N06AX18

ATC

reboxetine; oral

36.4

307.7

463

131

N06AX12

ATC

bupropion; oral

19.1

307.7

3784

2645

N05AE05

ATC

lurasidone; oral

1729.9

307.7

326

F99

ICD-10 Finland

Mental disorder, not otherwise specified

99.7

307.7

1090

118

SPAT1240

SPAT

Therapeutic discussion

6.9

307.7

3503

6374

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

8.6

307.7

854

1041

D01

ICPC

Abdominal pain/cramps general

2.9

307.7

2601

10122

N05AL01

ATC

sulpiride; systemic

67.5

307.7

597

N05BA04

ATC

oxazepam; oral

12.5

307.7

7872

12794

F84.5

ICD-10 Finland

Asperger syndrome

59.3

307.7

314

AA400

NOMESCO Finland

Electroconvulsive therapy

5306.6

307.7

523

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.6

307.7

2940

12707

Z72.2

ICD-10 Finland

Drug use

137.9

307.7

377

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

+∞

307.7

503

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

30.3

307.7

396

134

N05AB01

ATC

dixyrazine; systemic

90.2

307.7

489

N06AA04

ATC

clomipramine; systemic

27.6

307.7

644

243

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

307.7

3806

19076

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

1835.2

307.7

378

N03AF01

ATC

carbamazepine; oral, rectal

7.4

307.7

1086

1562

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.4

307.7

1415

4483

F40.1

ICD-10 Finland

Social phobias

28.7

307.7

1413

544

N06AB03

ATC

fluoxetine; oral

17.5

307.7

4831

4043

N05AE04

ATC

ziprasidone; systemic

1646.8

307.7

465

P29

ICPC

Psychological sympt/compl other

10.9

307.7

3506

4142

N05AF05

ATC

zuclopenthixol; systemic

2563.9

307.7

516

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

29.7

307.7

673

237

WX110

NOMESCO Finland

Infiltration anesthesia

2.3

307.7

11160

87689

N05AB03

ATC

perphenazine; systemic, rectal

184.9

307.7

2143

136

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

4105.1

307.7

410

F60.1

ICD-10 Finland

Schizoid personality disorder

817.6

307.7

399

C07AB07

ATC

bisoprolol; oral

2.2

307.7

5328

30648

SPAT1243

SPAT

Psychiatric/psychological examination

9.6

307.7

947

1051

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

26.0

307.7

863

351

N06AX26

ATC

vortioxetine; oral

11.2

307.7

2825

3067

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.3

307.7

3807

19611

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1055.8

307.7

1166

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

307.7

3639

18906

F50.2

ICD-10 Finland

Bulimia nervosa

105.0

307.7

379

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.3

307.7

642

1057

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

85.1

307.7

3461

534

N05AD01

ATC

haloperidol; systemic

55.9

307.7

1145

222

P28

ICPC

Limited function/disability (P)

52.1

307.7

396

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

3.2

307.7

1732

5949

R53

ICD-10 Finland

Malaise and fatigue

2.7

307.7

4436

20151

T36

ICD-10 Finland

Poisoning by systemic antibiotics

221.5

307.7

3490

208

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

23.7

307.7

415

180

ZXY49

NOMESCO Finland

Other health care provider

+∞

307.7

317

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

243.5

307.7

357

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

192.7

307.7

321

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3406.1

307.7

672

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.8

307.7

2118

6183

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

11.3

307.7

432

392

SPAT1301

SPAT

No procedures

2.3

307.7

4517

24058

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

116.3

307.7

4146

500

P74

ICPC

Anxiety disorder/anxiety state

14.9

307.7

2208

1726

Z2445

NOMESCO Finland

Psychologist

26.3

307.7

1743

749

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.0

307.7

2157

8051

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

23.7

307.7

278

119

IER01

NOMESCO Finland

Psychoeducation, group

+∞

307.7

541

S06.0

ICD-10 Finland

Concussion

3.5

307.7

2077

6599

P03

ICPC

Feeling depressed

7.9

307.7

3786

6259

F60.0

ICD-10 Finland

Paranoid personality disorder

1246.5

307.7

599

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

1035.8

307.7

404

ICB01, ,

SPAT

22.9

307.7

312

139

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

307.7

465

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

178.4

307.7

998

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

322.4

307.7

316

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

127.1

307.7

348

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2897.9

307.7

852

F93.89

ICD-10 Finland

Other childhood emotional disorders

1950.3

307.7

400

N06AX17

ATC

milnacipran; oral

29.4

307.7

398

139

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

13.4

307.7

4894

5336

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

307.7

2963

13574

Z2221

NOMESCO Finland

Medical doctor

2.4

307.7

4301

21929

WX290

NOMESCO Finland

Other blockage of nerve

2.0

307.7

8439

59794

Z72.1

ICD-10 Finland

Alcohol use

20.5

307.7

399

199

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

1221.0

307.7

699

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

6267.0

307.7

612

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

307.7

2094

7622

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

164.2

307.7

793

F41.01

ICD-10 Finland

Severe panic disorder

141.5

307.7

319

N06AX21

ATC

duloxetine; oral

8.7

307.7

3526

5157

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.9

307.7

1209

1880

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

16.4

307.7

293

182

N06BA04

ATC

methylphenidate; oral

16.0

307.7

1492

1032

N03AG01

ATC

valproic acid; systemic, rectal

37.3

307.7

3309

1143

T90

ICPC

Diabetes non-insulin dependent

2.5

307.7

2966

13481

30180

ICD-8 Finland

Personality disorders, Immatura

+∞

307.7

684

IHZ05, ,

SPAT

5.6

307.7

1476

2879

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

307.7

447

P16

ICPC

Acute alcohol abuse

31.1

307.7

644

216

F45.0

ICD-10 Finland

Somatization disorder

71.1

307.7

190

F32.8

ICD-10 Finland

Other depressive episodes

28.0

307.7

704

263

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

54.2

307.7

230

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

113.0

307.7

902

XF400

NOMESCO Finland

ECG with 12 standard connections

3.3

307.7

2065

6943

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

1024.6

307.7

958

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

705.9

307.7

346

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3224.9

307.7

326

N05AH04

ATC

quetiapine; oral

44.1

307.7

8969

5290

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

66.1

307.7

209

Z3231

NOMESCO Finland

Registered nurse

3.4

307.7

4649

17905

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

417.4

307.7

329

R02

ICPC

Shortness of breath/dyspnoea

3.5

307.7

2388

7756

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

307.7

3150

15432

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

307.7

6625

42591

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

307.7

422

N07BB01

ATC

disulfiram; oral

33.7

307.7

2070

713

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4200.1

307.7

419

C03CA01

ATC

furosemide; systemic

2.6

307.7

2619

11145

S29

ICPC

Skin symptom/complaint other

2.5

307.7

3271

15390

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

49.0

307.7

1593

364

N06AX03

ATC

mianserin; oral

28.3

307.7

1846

745

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

+∞

307.7

491

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

51.4

307.7

894

185

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

132.1

307.7

183

P76

ICPC

Depressive disorder

17.7

307.7

3280

2363

P15

ICPC

Chronic alcohol abuse

26.9

307.7

1199

484

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4052.4

307.7

405

P80

ICPC

Personality disorder

321.4

307.7

587

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

+∞

307.7

313

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

42.0

307.7

4382

1489

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

4088

21284

F41.8

ICD-10 Finland

Other specified anxiety disorders

7.8

307.7

1124

1553

ICB06, ,

NOMESCO Finland

2404.2

307.7

486

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

9.3

307.7

4200

6137

F05.9

ICD-10 Finland

Delirium, unspecified

18.5

307.7

318

175

N06AB05

ATC

paroxetine; oral

14.9

307.7

2298

1807

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

15.6

307.7

1954

1432

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

307.7

6430

36026

N05AC01

ATC

periciazine; systemic

109.4

307.7

216

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.7

307.7

653

1011

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.7

307.7

2826

12066

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

24.6

307.7

726

309

Z08

ICPC

Social welfare problem

21.0

307.7

438

214

EBA00

NOMESCO Finland

Extraction of tooth

2.4

307.7

6484

37075

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.5

307.7

1970

4013

N05BA06

ATC

lorazepam; systemic, sublingual

26.5

307.7

1790

768

P27

ICPC

Fear of mental disorder

16.8

307.7

541

334

F33

ICD-10 Finland

Recurrent depressive disorder

15.4

307.7

992

687

D11

ICPC

Diarrhoea

2.7

307.7

2479

10154

N05AX12

ATC

aripiprazole; systemic

490.2

307.7

3375

A01

ICPC

Pain general/multiple sites

4.5

307.7

2086

5201

V03AA01, ,

ATC

41.2

307.7

568

143

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

632.2

307.7

1477

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

307.7

363

N06AA12

ATC

doxepin; systemic

17.0

307.7

1446

938

N05BA01

ATC

diazepam; systemic, rectal

14.2

307.7

4430

4375

SPAT1234

SPAT

Support of social functional capacity

12.0

307.7

950

840

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4570.6

307.7

454

IAB01, ,

SPAT

41.8

307.7

247

ICB03, ,

SPAT

69.5

307.7

206

T74.1

ICD-10 Finland

Physical abuse

10.6

307.7

732

722

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

146.3

307.7

245

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

11.7

307.7

520

457

N06AA09

ATC

amitriptyline; systemic

6.8

307.7

1925

3202

F31.8

ICD-10 Finland

Other bipolar affective disorders

426.2

307.7

1526

IGY99

NOMESCO Finland

Other psychiatric treatment contact

159.5

307.7

1399

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

24.4

307.7

1579

723

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

18.6

307.7

1405

831

N05BA02

ATC

chlordiazepoxide; systemic

39.7

307.7

893

239

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

284.2

307.7

388

IGP01

NOMESCO Finland

Psychiatric family contact

122.4

307.7

312

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.4

307.7

1018

2438

IEY01

NOMESCO Finland

Psychoeducation, individual

381.9

307.7

552

N06AA06

ATC

trimipramine; systemic

21.5

307.7

803

393

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.5

307.7

2022

4187

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

18.2

307.7

500

283

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

192.6

307.7

2408

150

Z02.7

ICD-10 Finland

Issue of medical certificate

3.8

307.7

1404

4009

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1023.3

307.7

2173

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

5.5

307.7

2077

4258

M79.7

ICD-10 Finland

Fibromyalgia

6.1

307.7

825

1426

N05AC02

ATC

thioridazine; oral

23.9

307.7

788

348

IAA02

NOMESCO Finland

Consultation concerning further psychiatric treatment

132.8

307.7

171

F10.24

ICD-10 Finland

Alcohol depence active use

124.4

307.7

745

IGY02

NOMESCO Finland

Psychiatric monitoring contact

117.4

307.7

2014

199

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

72.9

307.7

1217

182

Z2446

NOMESCO Finland

Social worker

14.3

307.7

2299

1894

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

9262

66758

Z71.8

ICD-10 Finland

Other specified counselling

2.2

307.7

5843

34278

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

367.2

307.7

463

F10.20

ICD-10 Finland

Alcohol dependence currently independent

195.9

307.7

1238

SAA01

NOMESCO Finland

Simple examination of mouth

2.4

307.7

11525

91518

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

307.7

516

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

64.4

307.7

1887

336

F10.25

ICD-10 Finland

Alcohol dependence continuous use

170.5

307.7

791

ZY010

NOMESCO Finland

Hospital outpatient

26.3

307.7

2594

1192

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

30.9

307.7

274

F60.7

ICD-10 Finland

Dependent personality disorder

582.9

307.7

615

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

307.7

358

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

24.2

307.7

307

129

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

+∞

307.7

416

P99

ICPC

Psychological disorders other

40.5

307.7

1885

533

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

122.9

307.7

4746

576

N06AB08

ATC

fluvoxamine; oral

21.1

307.7

938

474

IHZ07, ,

SPAT

43.7

307.7

296

T82

ICPC

Obesity

4.1

307.7

1044

2711

ZYY01

NOMESCO Finland

Contact between professionals

118.3

307.7

279

R11

ICD-10 Finland

Nausea and vomiting

3.4

307.7

1635

5180

N03AE01

ATC

clonazepam; systemic

15.8

307.7

1999

1454

IGY02, ,

SPAT

43.1

307.7

838

206

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

263.2

307.7

4073

216

F32.9

ICD-10 Finland

Depressive episode, unspecified

36.9

307.7

6779

3421

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

307.7

5937

34957

N05CD02

ATC

nitrazepam; oral

24.2

307.7

401

170

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

78.6

307.7

1472

208

N06AX16

ATC

venlafaxine; oral

20.4

307.7

6394

5456

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12939

109345

3.00

321.41

6.2

3.9

6.01

5.69

mmol/l

95.97

12260

103332

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

489

597

8.43

307.65

2.0

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

9779

63808

2.69

307.65

14.8

8.3

4.22

3.96

e9/l

24.78

8498

55911

(3013115) Eosinophils [#/volume] in Blood

9204

59213

2.56

307.65

9.1

6.0

0.19

e9/l

1.10

8031

52961

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2990

14395

2.36

307.65

2.5

2.47

2.42

g/l

5.41

2677

13531

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3776

17795

2.52

307.65

1.9

1.6

29937731.86

36001711.57

pmol/l

0.24

3190

15530

(3019198) Lymphocytes [#/volume] in Blood

9114

58890

2.51

307.65

8.2

6.0

2.07

1.95

e9/l

10.37

7978

53112

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6250

31446

2.75

307.65

3.4

2.4

55.26

66.18

u/l

2.37

5737

29517

(3044889) 12 lead EKG panel

10126

73953

2.27

307.65

4.5

3.1

0.38

2274.65

0.55

115

(3027008) Opiates [Presence] in Urine

3088

6592

5.69

307.65

4.5

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9027

51983

3.00

307.65

6.3

6.1

9.47

10.87

umol/l

20.45

8500

49563

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5218

24546

2.77

307.65

2.6

2.2

2.64

2.61

mg/l

0.37

4529

21520

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8113

38229

3.60

307.65

7.2

6.1

1.21

mmol/l

0.03

7655

35792

(3026008) Bacteria identified in Urine by Culture

5137

28020

2.30

307.65

3.6

2.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

7792

41170

2.96

307.65

4.9

5.1

36.44

36.88

g/l

9.78

7308

39007

(3018418) pH of Serum or Plasma

5873

25346

3.23

307.65

4.0

4.2

7.40

0.19

4171

17713

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2503

9373

3.02

307.65

2.0

2.3

368.06

378.30

nmol/l

1.83

2309

8811

(3023103) Potassium [Moles/volume] in Serum or Plasma

13548

115544

4.58

307.65

24.0

11.8

3.93

3.94

mmol/l

3.66

13372

112737

(3032080) INR in Blood by Coagulation assay

6594

40702

2.15

307.65

10.0

9.7

1.12

1.16

inr

3.81

5537

33537

(3021589) Normoblasts [#/volume] in Blood

7473

51260

1.96

307.65

13.2

9.5

0.00

e9/l

0.16

6021

42355

(40758558) Short blood count panel - Blood

5584

31620

2.25

307.65

8.2

5.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2426

9374

2.91

307.65

2.1

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3553

15914

2.64

307.65

2.6

2.9

2.43

mmol/l

0.06

3117

14401

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

873

+∞

307.65

16.8

0.0

830.68

—

nmol/l

—

852

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

544

166

33.95

307.65

4.0

1.2

174.28

73.45

umol/l

4.94

296

(3024354) Oxygen [Partial pressure] in Venous blood

1894

5970

3.50

307.65

3.8

3.1

4.80

4.65

kpa

2.01

1819

5825

(3021960) Folate [Moles/volume] in Serum or Plasma

5549

22206

3.45

307.65

1.9

1.5

19.27

20.04

nmol/l

3.86

5009

19343

(3015736) pH of Urine

7357

49148

2.02

307.65

4.3

2.9

6.32

6.17

23.19

4099

28651

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

872

136

68.07

307.65

2.9

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3640

10036

4.52

307.65

1.9

1.6

1142.54

1173.04

nmol/l

1.15

2926

7819

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2576

3180

9.65

307.65

2.2

1.4

0.25

mg/l

0.25

1221

1433

(3027944) Amphetamines [Presence] in Urine

2977

6611

5.42

307.65

4.3

1.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

11074

83807

2.44

307.65

4.6

3.9

10.84

9.41

mm/h

26.71

10451

79742

(3019977) pH of Arterial blood

2297

8852

2.89

307.65

8.8

8.2

7.41

7.42

4.41

1250

4617

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7848

48818

2.35

307.65

2.9

2.3

70.70

75.39

nmol/l

41.85

7366

45927

(3028300) Cannabinoids [Presence] in Urine

3095

6615

5.69

307.65

4.6

1.2

—

(3019150) Specific gravity of Urine by Refractometry

4931

26346

2.33

307.65

4.7

3.2

1.02

1.20

kg/l

1.09

3232

16771

(3001604) Monocytes [#/volume] in Blood

8978

56981

2.55

307.65

8.1

6.0

0.57

0.55

e9/l

10.69

7715

50250

(3015377) Calcium [Moles/volume] in Serum or Plasma

6529

30739

3.07

307.65

2.9

3.6

2.35

mmol/l

0.80

6020

28577

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12299

92843

3.38

307.65

6.2

4.0

14.27

14.50

pmol/l

24.74

11617

86879

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13124

109877

3.48

307.65

8.0

4.7

1.77

1.79

mu/l

1.59

12575

104187

(3006315) Basophils [#/volume] in Blood

8994

57050

2.56

307.65

8.1

6.0

0.04

e9/l

0.27

7711

50263

(3016502) Oxygen saturation in Arterial blood

2039

7760

2.89

307.65

9.0

8.8

95.21

96.22

9.61

1987

7492

(3019069) Monocytes/Leukocytes in Blood

8211

52278

2.34

307.65

8.1

6.2

8.28

8.58

21.41

7713

49627

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2000

7931

2.76

307.65

2.4

0.22

g/l

0.11

1829

7544

(4198724) Urine methamphetamine measurement

731

107

71.79

307.65

3.1

1.1

—

(36304419) Bacteria [Presence] in Urine

4723

26036

2.21

307.65

3.4

2.8

103.62

36.50

estimate

0.26

(3018095) Leukocytes [#/volume] in Urine

6339

38836

2.13

307.65

4.5

3.4

61.08

71.36

e6/l

0.78

4453

25815

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2366

8958

2.96

307.65

2.1

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2244

7310

3.45

307.65

4.3

3.8

5.95

5.79

kpa

9.27

2176

7148

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1500

4394

3.69

307.65

4.5

4.1

24.31

24.24

mmol/l

0.41

1466

4365

(3009466) Valproate [Moles/volume] in Serum or Plasma

1461

305

53.14

307.65

6.9

2.8

376.17

357.36

umol/l

1.25

1304

261

(3031040) Bacteria [#/volume] in Urine by Automated count

10064

73839

2.23

307.65

6.1

3.6

1883.33

1296.95

e6/l

0.38

177

868

(3016879) Cocaine [Presence] in Urine

3031

5823

6.33

307.65

4.6

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8764

43705

3.61

307.65

7.6

6.6

1.21

mmol/l

1.85

7740

37994

(3018010) Neutrophils/Leukocytes in Blood

8180

53604

2.23

307.65

7.9

5.9

56.41

56.36

0.15

7836

51711

(3000850) Epithelial cells [#/volume] in Urine

3997

21046

2.24

307.65

2.9

2.5

8.26

6.07

e6/l

9.20

3650

19079

(3020191) Ethanol [Moles/volume] in Serum or Plasma

608

368

17.17

307.65

2.1

1.1

1.25

0.88

promille

4.35

458

296

(3022096) Basophils/Leukocytes in Blood

8164

52129

2.32

307.65

8.1

6.2

0.65

0.69

11.19

7657

49304

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2681

10618

2.87

307.65

5.3

6.6

1.05

1.04

mmol/l

0.72

2499

9995

(3026782) Osmolality of Urine

3530

17387

2.36

307.65

2.9

2.6

505.11

547.06

mosm/kgh2o

19.57

3078

15301

(3006504) Eosinophils/Leukocytes in Blood

8169

52173

2.32

307.65

8.0

6.2

2.64

2.87

17.81

7670

49460

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3305

14332

2.69

307.65

3.2

3.6

0.82

0.83

mmol/l

3.90

3082

13666

(3009508) Creatinine [Moles/volume] in Urine

6600

32331

2.93

307.65

4.6

3.3

7.53

8.31

mmol/l

26.06

5772

28449

(3042517) Benzodiazepines panel - Urine

282

286.98

307.65

3.2

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2273

8846

2.86

307.65

8.7

8.2

5.24

5.05

kpa

14.27

2197

8531

(3000764) Benzodiazepines [Presence] in Urine

3104

6509

5.81

307.65

4.6

1.2

—

(3003396) Base excess in Arterial blood by calculation

2271

8775

2.88

307.65

8.7

8.2

1.24

0.65

mmol/l

8.94

1898

7147

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11926

81084

3.90

307.65

9.0

7.4

77.17

74.42

u/l

7.77

11438

77402

(3011288) Drugs identified in Urine by Screen method Nominal

2916

3216

11.12

307.65

6.0

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

704

1210

6.05

307.65

2.4

3.1

34.01

35.11

umol/l

0.32

638

1118

(3028707) Methadone [Presence] in Urine by Screen method

2502

633

47.63

307.65

4.7

1.3

—

(3002030) Lymphocytes/Leukocytes in Blood

8314

54584

2.25

307.65

8.1

6.1

29.40

29.33

0.23

7888

52310

(3002582) Erythrocytes [#/volume] in Urine

5584

31366

2.28

307.65

3.7

2.9

49.78

67.70

e6/l

0.93

4309

23342

(3014111) Lactate [Moles/volume] in Serum or Plasma

2093

6985

3.33

307.65

8.0

8.5

1.36

1.25

mmol/l

5.40

2045

6884

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

374

62.79

307.65

2.1

2.8

15.37

19.47

umol/l

1.51

374

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5442

26548

2.69

307.65

2.8

1.9

277.69

192.19

u/l

5.02

5159

25283

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2311

9185

2.80

307.65

3.1

2.4

38.18

42.39

u/l

0.37

1949

7880

(3030467) Casts [#/volume] in Urine by Automated count

4935

26767

2.29

307.65

3.5

2.9

0.38

0.32

e6/l

1.02

3647

18921

(3002032) Base excess in Venous blood by calculation

2205

7142

3.46

307.65

4.3

3.8

1.78

1.69

mmol/l

0.44

1956

6301

(3027801) Oxygen [Partial pressure] in Arterial blood

2273

8840

2.86

307.65

8.7

8.2

11.66

13.56

kpa

55.04

2194

8528

(3013826) Glucose [Moles/volume] in Serum or Plasma

9330

60654

2.55

307.65

6.7

4.3

6.58

6.47

mmol/l

4.89

8847

55682

(3019550) Sodium [Moles/volume] in Serum or Plasma

13542

115194

4.62

307.65

24.0

11.6

139.45

139.71

mmol/l

31.74

13380

112683

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3132

13393

2.71

307.65

2.2

1.8

—

(3023368) Bacteria identified in Blood by Culture

4672

22952

2.53

307.65

5.0

3.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3171

15770

2.29

307.65

2.5

13.12

14.55

umol/l

21.26

2926

14953

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7691

36697

3.38

307.65

4.3

3.0

33.11

31.59

u/l

0.30

7250

35008

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5538

13026

6.31

307.65

2.6

1.4

1.56

1.25

212.82

4993

11822

(3012544) pH of Venous blood

2249

7485

3.37

307.65

4.3

3.8

7.37

7.38

1.36

1271

4191

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7824

39006

3.23

307.65

2.4

1.8

96.60

98.10

pmol/l

2.12

4519

21317

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11379

87863

2.46

307.65

5.5

2.7

45.92

38.22

u/l

23.29

10872

84476

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1935

7439

2.85

307.65

9.3

9.2

124.35

123.02

g/l

1.99

1902

7257

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3229

16645

2.21

305.56

4.3

3.1

274.65

577.97

ng/l

2.31

2002

10843

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5058

30838

1.99

304.59

1.5

1.3

1.66

1.62

u/ml

0.07

1264

9561

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1217

3879

3.33

302.63

3.6

2.9

1.78

1.18

31.75

1212

3854

(3037467) Urinalysis macro (dipstick) panel - Urine

10256

79428

2.03

300.21

5.4

3.8

2.00

6.96

—

116

(3033658) Prothrombin time (PT) actual/Normal

4402

25722

2.02

297.76

5.0

3.6

95.02

93.76

2.97

4279

25147

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

391

482

8.29

293.74

2.2

1.3

1955433.67

1625244.62

iu/ml

0.18

(3004119) Hemoglobin [Mass/volume] in Venous blood

1341

4637

3.08

290.53

3.3

3.2

132.30

132.34

g/l

0.02

1306

4536

(3007853) Bacteria identified in Skin by Aerobe culture

2515

11911

2.34

290.11

2.0

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5451

34544

1.93

289.32

4.3

2.7

25.85

44.96

ng/l

3.82

3287

18307

(3023511) Choriogonadotropin [Units/volume] in Urine

1218

4018

3.21

285.75

1.6

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

175

38.41

284.78

1.2

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2669

13066

2.28

284.25

2.6

21.46

24.35

23.18

2435

12334

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2441

11561

2.34

280.75

2.5

2.7

6.86

7.34

umol/l

0.45

1933

10209

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4007

23167

2.01

275.37

2.8

2.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3109

16382

2.14

274.65

3.1

2.6

1.15

0.93

e6/l

2.21

1560

8366

(3017143) Hepatitis C virus Ab [Presence] in Serum

3349

18358

2.07

265.27

1.9

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2898

15117

2.15

261.26

3.2

2.7

4.67

3.00

e6/l

7.61

1326

7062

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1322

4834

2.91

258.18

3.4

3.1

5.27

5.08

kpa

12.88

1269

4645

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1355

5084

2.83

252.05

10.5

1.70

1.24

22.90

1348

5060

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8418

62877

1.82

251.64

3.9

3.0

90.00

96.30

ug/l

1.45

7864

60210

(3013512) EKG study

4737

29723

1.88

250.61

3.7

2.9

0.89

0.78

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1685

7080

2.56

250.39

6.2

8.5

7.67

8.72

mmol/l

8.45

1616

6850

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4218

25520

1.92

249.34

3.0

2.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1153

3991

3.05

248.11

3.2

3.0

1.79

1.46

mmol/l

2.01

847

2841

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1188

4183

3.00

248.06

1.9

1.5

—

(3009343) pH of Capillary blood

1274

4680

2.88

246.30

3.4

3.1

7.41

7.42

8.87

1108

3847

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1315

4924

2.83

245.29

10.7

10.9

0.62

0.65

2.26

1307

4903

(3021387) Prolactin [Units/volume] in Serum or Plasma

1611

6710

2.57

243.46

1.9

1.6

441.66

266.16

mu/l

11.99

1408

6116

(3042936) Bacteria identified in Isolate by Culture

2647

13672

2.14

242.93

2.2

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3665

21353

1.96

241.06

2.9

2.8

921.70

874.94

ng/l

0.24

2936

17812

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1392

5439

2.72

239.08

8.7

8.6

25.02

24.59

mmol/l

3.87

1371

5413

(3011397) Hemoglobin [Presence] in Urine by Test strip

4300

26480

1.89

238.81

4.1

3.2

0.67

0.18

1.08

202

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1233

4536

2.87

237.45

7.6

6.4

24.89

24.29

mmol/l

5.70

1193

4315

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

839

2475

3.53

234.35

2.3

539.04

661.59

ug/l

0.35

781

2308

(3019060) Gas panel - Arterial blood

1152

4148

2.93

230.55

4.9

4.7

—

(3027945) Reticulocytes/Erythrocytes in Blood

1890

8683

2.35

229.80

2.6

2.7

1.78

1.73

1.12

1671

7903

(3007164) IgA [Mass/volume] in Serum or Plasma

4255

26488

1.86

225.98

1.5

1.4

2.23

g/l

0.00

2358

18267

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1226

4618

2.80

225.50

10.6

10.7

24.49

24.13

mmol/l

3.04

1186

4563

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1163

4355

2.81

216.01

1.7

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

4548

29311

1.81

213.13

4.4

4.2

10.02

8.23

mg/mmol

1.33

2857

18678

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1427

5991

2.53

210.70

1.7

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

8283

63373

1.73

209.66

4.5

3.2

11.71

2.59

estimate

2.52

1757

12894

(3015235) Bicarbonate [Moles/volume] in Capillary blood

813

2544

3.32

206.49

3.0

2.6

24.95

24.38

mmol/l

3.54

798

2513

(21494755) Public health laboratory ask at order entry panel

727

20289

0.32

204.85

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

8300

63792

1.72

204.11

4.5

3.2

0.62

0.26

estimate

0.26

1683

12371

(3024928) Oxygen saturation in Venous blood

692

1969

3.63

203.73

3.0

3.6

63.90

64.20

0.12

647

1934

(3012516) Albumin [Mass/volume] in Urine

4464

28925

1.79

203.41

3.7

3.6

50.11

50.45

mg/l

0.03

2886

18574

(3021601) Nitrite [Presence] in Urine by Test strip

8154

62727

1.70

196.36

4.5

3.2

0.00

estimate

0.09

1743

12836

(3048689) Calprotectin [Mass/mass] in Stool

3024

17530

1.92

196.14

2.3

2.8

106.00

120.81

ug/g

1.99

2316

14273

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12366

107665

2.12

194.75

7.3

4.8

38.69

37.74

mmol/mol

21.05

11715

103237

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1348

5755

2.48

191.26

1.1

1.26

5.48

u/ml

0.84

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2481

13563

2.00

190.60

2.1

2.2

29.32

29.39

0.24

2402

13218

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

964

3492

2.88

189.84

4.5

3.5

53.13

48.15

7.51

943

3448

(3020891) Body temperature

932

3324

2.92

188.82

6.0

4.0

36.95

36.91

°c

2.46

920

3298

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

909

22032

0.37

188.37

1.7

1.8

3.55

3.49

ratio

0.52

636

16376

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3940

25071

1.79

188.10

2.0

1.7

0.99

1.04

mg/l

0.49

2906

19083

(36660697) Celiac disease serology panel - Serum

1975

10065

2.11

183.28

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

618

1752

3.63

182.72

3.1

2.9

8.53

8.61

kpa

0.56

601

1713

(1616796) Gas panel - Central venous blood

598

1660

3.71

182.41

3.8

3.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1598

7597

2.24

176.45

3.0

3.9

4.46

4.62

pmol/l

8.96

1406

7040

(3027273) Bicarbonate [Moles/volume] in Venous blood

869

3130

2.88

172.58

3.5

3.1

25.37

25.25

mmol/l

0.41

846

3022

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1307

5806

2.37

168.98

2.4

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1119

4675

2.51

165.48

10.4

16.36

16.34

0.05

1088

4495

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

105

34.03

165.26

2.1

1.0

2.51

—

mmol/l

—

(3008295) Osmolality of Serum or Plasma

344

672

5.21

165.11

1.8

1.4

282.14

280.98

mosm/kgh2o

0.32

267

550

(3018405) Lactate [Moles/volume] in Arterial blood

687

2221

3.19

164.81

4.4

3.6

1.39

1.33

mmol/l

0.78

681

2183

(3023520) Reticulocytes [#/volume] in Blood

1380

6361

2.29

163.54

2.3

2.8

73.62

70.81

e9/l

1.87

952

4582

(3000494) Fungus identified in Specimen by Culture

2343

13224

1.92

161.33

1.6

1.4

—

(3021901) Oxygen saturation in Capillary blood

524

1458

3.68

159.10

3.0

2.8

91.11

91.52

0.78

509

1422

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13254

120496

2.43

157.57

21.2

11.1

21.19

21.80

mg/l

1.48

11394

95455

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1825

9615

2.02

152.84

7.9

4.8

—

(40768797) Stomach Pathology biopsy report

2383

13778

1.87

151.41

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5181

37109

1.62

151.36

2.6

2.0

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

12592

112650

2.00

149.14

18.7

10.4

93.33

89.62

ml/min/173m2

76.20

11789

101864

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2677

16116

1.81

148.99

2.8

2.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

701

2435

2.97

148.31

1.4

293.62

287.85

ug/g

0.17

376

1338

(3003181) Sodium [Moles/volume] in Urine

397

977

4.14

143.23

1.6

1.3

56.18

65.32

mmol/l

3.22

296

793

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1239

5809

2.24

140.06

2.5

2.0

6.12

8.59

ug/l

2.52

1068

5234

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

687

16782

0.38

139.68

1.6

3.45

3.48

mmol/l

0.27

443

11085

(3010421) pH of Blood

705

2541

2.86

139.33

4.0

3.2

7.40

7.41

4.32

684

2516

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2267

13232

1.84

138.60

2.5

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

4619

32865

1.60

134.78

4.8

3.3

0.00

0.01

estimate

1.10

1656

12150

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1660

8875

1.98

132.14

4.3

2.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1481

7615

2.05

131.51

1.5

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13668

127348

2.82

130.75

25.3

13.3

72.12

72.98

umol/l

2.72

13591

126030

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1321

6578

2.11

127.69

3.6

3.7

1.22

1.23

mmol/l

1.70

1109

5781

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

610

2135

2.93

127.07

1.2

3.89

3.62

mmol/l

6.39

563

2032

(3012501) Base excess in Blood by calculation

506

1598

3.24

125.88

4.5

3.4

2.61

2.23

mmol/l

1.63

316

1007

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

565

1905

3.04

125.77

1.8

1.6

521.30

361.53

mu/l

4.09

458

1576

(3013290) Carbon dioxide [Partial pressure] in Blood

506

1599

3.24

125.75

4.5

3.4

5.16

4.94

kpa

7.23

484

1570

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1098

5113

2.24

125.73

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

639

2312

2.84

125.22

2.9

2.7

1.96

2.12

index

0.19

355

1160

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

663

2447

2.79

125.14

1.2

1.3

437.36

510.30

mg/l

3.35

631

2365

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1701

9361

1.92

123.86

2.8

2.3

5746.72

6895.07

u/l

0.58

504

4187

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6247

48193

1.52

123.86

2.1

1.8

1.61

1.34

mmol/l

49.35

5350

42142

(3027315) Oxygen [Partial pressure] in Blood

505

1612

3.20

123.40

4.5

3.4

8.94

8.96

kpa

0.09

483

1583

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

597

2114

2.90

121.70

1.3

1.4

7.75

33.73

e6/l

5.75

431

1580

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

603

2150

2.88

121.38

1.4

611.60

1720.11

e6/l

1.64

460

1719

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1210

6067

2.08

114.33

3.7

4.1

85.47

85.29

ng/l

0.02

1058

5448

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

21.35

111.06

1.1

1.0

47.34

37.31

mg/l

1.98

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13632

127806

2.55

111.03

15.6

9.5

28.31

26.73

u/l

10.34

13403

124879

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

628

2430

2.65

107.90

1.6

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

1605

9076

1.86

106.48

5.1

4.5

0.72

0.92

2.04

472

2404

(3037522) Nuclear Ab [Titer] in Serum

2658

17349

1.65

106.16

1.4

410.09

550.08

titre

4.69

432

3573

(40767503) Oxygen content in Capillary blood by calculation

471

1576

3.05

106.13

3.3

2.3

17.02

17.17

0.46

459

1547

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

439

1433

3.12

103.21

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

439

1434

3.12

103.09

1.4

1.2

—

(3019225) pH of Specimen

1368

7477

1.91

100.55

3.9

3.7

7.36

7.35

1.66

1105

5289

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

837

3817

2.26

100.23

1.4

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

542

2023

2.74

99.90

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

549

2065

2.72

99.68

1.3

1.4

—

(3017509) Phencyclidine [Presence] in Urine

120

131

9.21

99.13

2.5

1.0

—

(3002179) Metamyelocytes/Leukocytes in Blood

1523

8690

1.84

97.69

4.8

4.3

0.61

0.65

0.25

442

2301

(3025159) Blasts/Leukocytes in Blood

1545

8924

1.82

95.08

5.6

4.7

0.05

0.44

3.32

358

2035

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3314

23314

1.54

94.90

1.4

1.3

23.11

30.53

iu/ml

2.15

826

7248

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

759

3415

2.29

93.74

5.5

4.7

2.13

1.58

14.97

720

3225

(3021440) Promyelocytes/Leukocytes in Blood

1514

8756

1.81

92.65

5.3

4.5

0.08

0.13

1.72

381

2091

(3006653) Thiamine [Moles/volume] in Blood

196

397

4.98

90.24

1.3

143.65

131.90

nmol/l

2.35

196

397

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1033

5375

1.99

87.29

2.6

117.11

141.11

ng/l

1.46

918

4836

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3060

21492

1.54

87.14

1.4

1.3

7.94

9.99

u/ml

0.83

969

9470

(3017732) Neutrophils [#/volume] in Blood

2206

14427

1.62

85.41

4.9

2.6

4.55

4.24

e9/l

1.10

1951

12998

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

11674

105879

1.56

85.18

28.2

13.1

13.60

13.33

102.29

11552

104438

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

228

548

4.20

84.88

1.4

1.5

72.42

72.19

0.08

214

528

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

525

2092

2.56

84.78

1.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

225

536

4.24

84.76

1.5

617.71

482.95

mu/l

0.64

211

516

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

146

239

6.15

84.64

2.8

3.0

28.47

27.51

umol/l

0.33

183

(3028271) Lactate [Moles/volume] in Capillary blood

354

1145

3.14

84.50

2.6

1.6

1.79

1.65

mmol/l

1.29

347

1116

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

600

2553

2.40

84.13

3.4

3.1

24.64

24.72

mmol/l

0.28

575

2366

(3005719) IgG [Mass/volume] in Serum or Plasma

1445

8469

1.78

84.12

2.4

2.8

10.46

10.70

g/l

1.56

1313

7913

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1340

7686

1.82

83.84

2.7

2.2

0.40

0.33

e6/l

0.41

1298

7290

(3009214) Lutropin [Units/volume] in Serum or Plasma

985

5124

1.99

83.18

1.4

1.3

9.06

9.05

u/l

0.01

737

4294

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1702

10495

1.70

82.62

1.3

1.2

100.13

150.35

u/ml

7.06

525

4324

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

251

7828

0.31

81.77

1.1

0.65

0.63

ratio

0.21

792

(3047181) Lactate [Moles/volume] in Blood

590

2531

2.38

81.21

6.3

5.2

1.29

1.22

mmol/l

1.14

527

2233

(3007566) Smooth muscle Ab [Titer] in Serum

700

3236

2.22

80.80

1.2

1.3

85.52

135.39

titre

1.62

343

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

627

2778

2.31

80.12

2.1

1.9

2.77

1.87

ug/l

1.11

571

2506

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

495

1973

2.56

79.86

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

681

3130

2.23

79.71

5.9

5.0

0.84

0.90

3.74

648

2953

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

290

8282

0.34

79.26

1.2

1.1

0.90

0.88

g/l

0.45

285

8266

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1293

7511

1.79

77.26

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1633

10181

1.68

75.62

3.2

4.9

224.01

236.61

u/l

3.70

1538

9790

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

632

2896

2.23

74.47

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

630

2892

2.23

73.90

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

630

2901

2.22

73.34

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1514

9362

1.69

72.12

1.5

1.3

20.77

23.74

iu/l

3.15

1171

8199

(42529406) Shigella sp [Presence] in Stool by Culture

629

2918

2.20

71.87

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

4634

36363

1.40

71.33

2.7

2.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1098

6243

1.82

70.22

2.0

2.7

66.52

67.12

g/l

1.94

1016

5895

(3006184) Hemoglobin [Mass/volume] in Capillary blood

483

2030

2.42

69.52

2.5

2.1

133.43

132.45

g/l

0.39

410

1577

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

894

15650

0.54

67.94

1.5

1.6

987.11

1015.22

mu/l

0.33

709

13498

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12818

120091

1.66

67.91

6.1

4.6

2.74

2.83

mmol/l

25.31

12105

115161

(3040151) Glucose [Moles/volume] in Capillary blood

277

892

3.14

66.65

8.1

3.5

7.79

7.01

mmol/l

0.74

224

738

(3034770) Mitochondria Ab [Titer] in Serum

654

3183

2.10

66.04

1.2

1.3

374.55

1034.21

titre

3.20

(3028026) IgM [Mass/volume] in Serum or Plasma

1122

6585

1.76

64.25

1.7

1.9

1.27

1.29

g/l

0.20

1019

6195

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

701

3551

2.02

63.47

1.8

1.9

1.54

1.40

g/l

3.41

614

3091

(3023410) Appearance of Cerebral spinal fluid

285

980

2.94

61.18

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

876

4862

1.85

60.33

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

222

5.38

60.23

6.1

2.7

5.18

4.83

kpa

2.63

119

222

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

222

5.38

60.23

6.1

2.7

10.32

10.77

kpa

0.71

119

222

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

266

898

2.99

59.01

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3524

27111

1.39

58.41

2.7

2.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5912

49316

1.34

58.15

4.5

3.0

0.15

0.16

estimate

0.02

1403

10689

(3013139) Helicobacter pylori Ag [Presence] in Stool

1296

8139

1.65

57.50

1.3

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

57.26

1.5

0.0

29.41

—

nmol/l

—

(3045716) Anion gap in Serum or Plasma by calculation

231

744

3.13

55.61

3.2

10.41

10.66

mmol/l

0.46

224

736

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12686

119436

1.55

55.50

5.4

4.3

4.59

4.74

mmol/l

60.02

12007

114981

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

+∞

54.14

1.8

0.0

236.73

—

ug/l

—

(3045414) Leukocytes [Presence] in Urine

1516

10060

1.56

53.24

2.1

1.9

0.00

0.04

estimate

9.44

331

2454

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

264

944

2.82

52.79

1.4

1.63

1.45

nmol/l

1.57

245

850

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

254

894

2.87

52.30

1.5

2.1

18.93

19.97

nmol/l

1.01

225

862

(4024509) Urine culture

804

4542

1.81

52.13

2.0

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3963

31542

1.35

51.89

2.0

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

109

215

5.09

51.87

1.0

30.28

30.53

ng/l

0.03

149

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

108

213

5.09

51.41

1.0

856.86

852.11

ng/l

0.03

145

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

383

1661

2.34

51.35

2.1

1.8

3232.94

1912.26

titre

0.82

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

108

216

5.02

50.59

1.0

210.55

238.69

ng/l

1.02

153

(3014051) Protein [Presence] in Urine by Test strip

4475

36412

1.33

50.05

3.1

2.5

0.14

0.02

0.75

508

(3044242) Glucose [Moles/volume] in Arterial blood

137

339

4.06

49.20

2.2

1.7

7.60

7.99

mmol/l

0.54

137

339

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

490

2406

2.07

48.24

1.5

1.3

20.74

23.37

u/l

1.10

383

2033

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

247

903

2.76

47.40

1.5

—

(3039000) Anion gap in Blood by calculation

369

1637

2.28

46.94

7.7

6.6

11.18

11.09

mmol/l

0.20

343

1471

(3018572) Chloride [Moles/volume] in Blood

369

1638

2.28

46.87

7.7

6.6

104.71

105.57

mmol/l

2.58

343

1472

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

427

2039

2.12

45.26

2.8

2.3

0.97

0.86

nmol/l

1.90

357

1785

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11983

112426

1.40

44.76

4.4

3.7

1.49

1.24

mmol/l

160.60

11197

107475

(40761536) Microorganisms panel - Urine sediment

1420

9638

1.52

44.57

4.5

3.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12575

119039

1.46

44.41

5.3

4.2

1.35

1.47

mmol/l

216.97

11848

114223

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

139

382

3.66

43.09

3.0

2.6

51.57

48.58

umol/l

0.52

118

345

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

876

5345

1.68

43.07

1.7

3.65

4.26

mg/l

1.46

754

3579

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

388

7717

0.49

43.04

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

153

451

3.41

42.64

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

518

9361

0.54

42.50

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

428

2097

2.07

42.39

1.7

2.2

0.00

g/l

0.50

389

1890

(3050129) First trimester maternal screen panel - Serum or Plasma

577

10086

0.55

42.22

1.4

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3534

28397

1.32

41.46

2.4

328.37

328.79

umol/l

0.09

3069

26113

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

407

1981

2.08

41.03

1.7

2.3

0.00

g/l

-0.00

388

1889

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

453

2301

2.00

40.61

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

120

311

3.87

40.50

2.1

2.3

19.42

32.83

umol/l

0.42

(3005322) IgE [Units/volume] in Serum or Plasma

1327

9065

1.51

40.19

1.4

1.3

269.17

215.45

u/ml

0.30

1216

8500

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

281

6115

0.45

40.02

1.4

1.5

57.16

60.45

ug/l

0.66

281

6115

(3022145) Colonoscopy Study observation

1752

12649

1.44

39.95

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1519

10701

1.47

39.43

2.9

2.2

11.14

13.10

nmol/l

14.52

1334

10022

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

524

2828

1.88

39.25

1.7

2.3

2.89

2.83

g/l

0.63

488

2654

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

436

2212

2.00

39.23

1.7

2.2

0.00

0.01

g/l

2.36

405

2042

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

479

2518

1.93

38.87

1.9

2.3

0.39

0.63

g/l

1.22

428

2255

(3009445) Proteinase 3 Ab [Units/volume] in Serum

697

4120

1.72

38.49

1.5

1.6

10.22

14.38

iu/ml

—

130

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1233

8381

1.51

38.16

2.4

2.3

17.41

20.51

au/ml

0.94

1238

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1159

7778

1.53

38.09

1.3

37.68

51.66

au/ml

1.29

545

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

105

259

4.07

37.96

2.9

2.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

772

4711

1.67

37.87

1.3

0.51

1.20

u/ml

2.11

351

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

475

2519

1.91

37.54

1.7

2.3

9.93

10.24

g/l

0.91

436

2334

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6413

56067

1.26

37.47

3.1

2.6

—

estimate

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

473

2513

1.91

37.18

2.6

2.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

461

2432

1.92

37.02

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

344

1634

2.13

37.01

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1033

6804

1.55

36.93

1.2

1.1

185.00

179.33

titre

0.03

232

(3025941) Bacteria identified in Stool by Culture

1060

7032

1.54

36.69

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

463

2457

1.91

36.52

2.0

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

410

2094

1.98

36.21

1.4

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

356

1732

2.08

35.96

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

210

815

2.59

35.92

1.2

1.3

1.88

1.93

mmol/l

0.35

186

771

(3036489) Thrombin time

732

4467

1.67

35.88

2.0

2.1

20.79

20.65

0.16

633

3833

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

531

2967

1.82

35.59

1.7

2.3

7.23

7.21

g/l

0.08

494

2793

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

530

2960

1.82

35.58

1.7

2.3

3.73

3.67

g/l

0.39

494

2786

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

536

2.98

35.53

1.6

36.75

7.87

nmol/l

0.39

127

429

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

530

2962

1.82

35.50

1.7

2.3

4.23

4.24

g/l

0.06

495

2790

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

269

1178

2.30

35.36

1.1

—

77.83

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

245

1030

2.40

35.35

5.1

6.3

10.85

11.03

mg/l

0.22

226

977

(3029634) Reagin Ab [Titer] in Serum by VDRL

404

2081

1.96

34.82

2.2

2.1

11.46

9.78

titre

0.11

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

236

990

2.40

34.23

1.5

1.2

5.15

6.06

umol/l

3.13

212

900

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

610

3593

1.72

34.10

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

304

1434

2.14

33.33

1.2

1.3

0.14

0.36

nmol/l

1.23

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

157

545

2.89

33.32

1.1

0.80

8.94

nmol/l

1.85

109

(3016038) Potassium [Moles/volume] in Urine

124

382

3.26

32.32

1.4

1.2

27.97

36.39

mmol/l

3.97

104

343

(3037121) Protein [Mass/volume] in Urine

528

3035

1.76

32.17

2.8

3.3

259.78

484.00

mg/l

3.03

245

1459

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

108

308

3.52

31.79

1.4

1.5

12.56

14.75

pmol/l

2.84

272

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

265

1213

2.20

31.37

1.1

—

15.02

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

384

2040

1.90

30.23

1.1

19.92

917.27

iu/ml

0.84

467

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

292

1414

2.08

29.93

1.2

1.3

2.00

3.46

nmol/l

0.30

280

1380

(3017315) Amylase [Enzymatic activity/volume] in Urine

132

442

3.00

29.92

1.4

1.2

260.31

342.12

u/l

0.46

121

406

(3003129) Base excess in Capillary blood by calculation

210

889

2.38

29.90

2.0

1.02

0.41

mmol/l

1.36

193

858

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

596

3622

1.67

29.66

1.9

2.2

2.95

3.98

iu/l

3.68

225

1644

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

413

2276

1.83

28.99

1.6

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

578

3509

1.67

28.88

2.3

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

311

1562

2.01

28.87

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

587

3582

1.66

28.75

1.8

1.9

0.24

0.23

g/l

0.73

554

3434

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

737

4756

1.58

28.71

1.6

1.7

13.61

11.82

u/ml

0.38

120

1529

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

530

3177

1.69

27.79

2.2

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

204

882

2.33

27.72

3.0

3.3

32.52

24.63

mu/l

1.75

184

841

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

252

1191

2.13

27.57

1.2

1.3

0.17

0.22

nmol/l

1.25

180

911

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

520

2.74

27.36

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

276

1354

2.05

27.36

1.5

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

597

3709

1.63

27.25

1.8

1.9

1.22

1.18

g/l

2.19

568

3565

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

227

1039

2.20

26.94

1.2

32.46

43.28

mg/l

4.31

192

879

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

457

2664

1.73

26.54

1.3

1.5

8.48

9.42

iu/ml

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

563

3471

1.64

26.50

2.2

1.8

181.05

202.52

pmol/l

3.46

532

3360

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

251

1204

2.10

26.43

1.2

1.3

—

nmol/l

—

(3017569) Oxygen content in Arterial blood

103

321

3.22

26.43

2.1

1.9

16.92

16.37

0.92

103

321

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

201

883

2.29

26.35

1.1

292.17

288.63

mg/l

0.29

178

815

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

410

2327

1.78

26.13

3.4

3.6

0.33

0.36

iu/ml

0.89

230

1243

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

745

4948

1.53

25.50

2.0

1.8

40.06

40.40

nmol/l

0.12

729

4879

(3008116) Ketones [Moles/volume] in Urine by Test strip

173

4.05

25.37

1.9

1.2

0.17

0.25

mmol/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

287

1471

1.97

25.20

1.3

—

13.00

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

211

966

2.20

25.06

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

287

1477

1.96

24.91

1.7

1.8

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1152

8366

1.41

24.83

2.7

2.4

76.63

73.91

ml/min/173m2

1.31

493

3275

(3020717) Zinc [Moles/volume] in Serum or Plasma

160

654

2.46

24.70

1.5

1.4

20.13

26.04

umol/l

1.91

147

612

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

255

3.42

24.65

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

273

1389

1.98

24.49

2.6

3.4

1.22

1.56

1.00

248

1271

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

135

513

2.64

24.25

1.3

1.2

68.11

73.05

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

389

2224

1.77

24.21

2.5

3.5

41.11

47.99

mg/l

1.02

328

1920

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

501

7905

0.62

24.16

1.4

1.5

1.22

1.16

ratio

0.77

280

4819

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

503

7925

0.62

24.11

1.4

1.5

1.25

1.18

ratio

1.00

285

4884

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

503

7925

0.62

24.11

1.4

1.5

0.94

ratio

0.05

282

4837

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

216

1017

2.14

23.92

1.1

202.12

246.13

mg/l

4.92

189

912

(3013005) Retinol [Moles/volume] in Serum or Plasma

131

495

2.66

23.81

1.7

1.8

1.97

1.94

umol/l

0.18

111

452

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

545

8407

0.63

23.79

1.5

58.20

62.59

ug/l

1.54

434

7104

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

252

3.38

23.68

1.4

1.2

115.68

116.05

nmol/l

0.01

200

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

387

2224

1.76

23.67

2.5

3.5

35.66

50.04

mg/l

1.17

327

1931

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

30.99

23.62

1.2

1.0

—

mmol/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

330

1812

1.84

23.51

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

494

7769

0.62

23.48

1.4

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

219

1048

2.10

23.27

1.7

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

348

1949

1.80

23.24

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

250

1260

2.00

23.07

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

249

1259

1.99

22.77

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

249

1259

1.99

22.77

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

249

1262

1.99

22.62

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

115

421

2.74

22.26

1.7

1.8

27.77

29.05

umol/l

0.66

106

394

(3023420) DNA double strand Ab [Units/volume] in Serum

741

5073

1.48

21.90

1.8

2.0

6.58

7.20

iu/ml

0.27

172

1235

(44813793) Dust mix specific IgE antibody measurement

199

942

2.12

21.78

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.31

21.70

2.1

2.2

—

(3011985) Renin [Units/volume] in Plasma

287

1549

1.87

21.63

1.6

78.10

57.26

mu/l

0.51

258

1416

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

469

2.61

21.47

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

168

3.81

21.40

1.3

1.2

0.30

0.31

nmol/l

0.02

116

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

268

1423

1.90

21.26

1.4

490.93

507.85

pmol/l

0.04

227

1234

(4027681) Cerebrospinal fluid IgG ratio and IgG index

174

790

2.21

21.17

1.2

1.3

0.58

0.68

ratio

1.63

460

(3024980) IgG subclass 4 [Mass/volume] in Serum

345

1987

1.75

20.98

1.5

1.6

0.70

0.75

g/l

0.41

260

1551

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

604

4002

1.53

20.91

2.1

2.2

95.11

94.61

0.21

578

3862

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

251

4565

0.54

20.79

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

41.59

20.39

1.9

1.2

2.15

2.06

g/l

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

341

1976

1.74

20.31

2.5

3.4

1.50

2.57

ratio

2.09

180

1117

(3035320) C reactive protein [Mass/volume] in Body fluid

173

799

2.17

20.20

3.2

2.3

26.52

28.20

mg/l

0.20

112

566

(3006922) Hepatitis E virus Ab [Presence] in Serum

197

959

2.06

20.07

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

235

1220

1.94

19.97

1.3

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1015

7485

1.38

19.87

1.3

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

569

3768

1.53

19.76

2.5

2.6

3.71

3.61

g/l

0.83

539

3604

(3001186) Copper [Moles/volume] in Serum or Plasma

283

3.01

19.62

1.3

1.4

16.50

16.64

umol/l

0.08

243

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

148

3.85

19.39

1.4

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

102

379

2.70

19.25

1.5

2.5

1.19

1.01

ug/l

0.39

353

(3025468) Yersinia sp identified in Specimen by Organism specific culture

219

1126

1.95

19.17

1.3

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

269

1481

1.83

19.08

1.2

1.3

30.42

29.83

u/l

0.03

237

1311

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

219

1131

1.95

18.93

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

219

1133

1.94

18.83

1.3

1.4

—

(3023419) Bacteria identified in Sputum by Culture

199

997

2.01

18.77

2.0

2.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1459

11457

1.30

18.62

4.5

4.0

29.96

32.22

12.62

1119

8333

(3014271) Vancomycin [Susceptibility]

171

3.57

18.59

2.9

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

783

5589

1.42

18.55

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

134

578

2.33

18.48

1.5

1.9

1.27

1.28

nmol/l

0.05

100

457

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

232

1232

1.89

18.46

1.1

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

227

1197

1.91

18.45

1.3

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

449

2865

1.58

18.42

1.2

1.3

277.28

243.39

u/ml

1.65

275

1862

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

157

726

2.17

18.33

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

157

726

2.17

18.33

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

157

726

2.17

18.33

1.6

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

554

3708

1.51

18.31

2.3

2.5

181.34

178.24

0.34

518

3536

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

327

1929

1.71

18.31

2.2

2.6

108.75

97.91

ug/min

0.15

194

1277

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

169

806

2.10

18.23

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

119

490

2.43

18.22

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

185

914

2.03

18.15

2.0

1.9

27.03

25.33

mg/l

0.17

360

(3008037) Lactate [Moles/volume] in Venous blood

302

1747

1.74

18.14

3.4

2.4

1.55

1.45

mmol/l

1.04

292

1705

(3051611) Lipemic interference index of Serum or Plasma

166

788

2.11

18.13

3.3

3.1

16.74

13.48

index

1.59

117

456

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

177

862

2.06

18.06

1.3

1.2

108.60

117.76

pmol/l

1.52

177

862

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

170

816

2.09

18.03

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

470

3048

1.56

17.97

1.2

37.96

45.06

u/ml

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

426

6517

0.64

17.84

1.5

—

(40768443) Skin Pathology biopsy report

682

4785

1.44

17.76

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

222

1178

1.89

17.73

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

225

1200

1.88

17.69

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

688

4840

1.44

17.66

1.9

2.2

41.11

39.96

u/l

0.72

617

4476

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

210

1096

1.93

17.63

1.7

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

157

738

2.13

17.60

1.4

1.5

7.48

6.80

ug/l

0.17

145

666

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

468

3058

1.54

17.31

1.6

1.4

0.38

0.47

nmol/l

0.95

368

2455

(3005033) Fetal Nuchal fold Thickness US

419

6370

0.65

17.04

1.5

1.23

1.26

0.36

278

4765

(3002619) Bacteria identified in Specimen by Culture

232

3.06

16.99

1.4

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1356

16965

0.78

16.90

2.6

2.8

0.56

0.72

ug/l

12.33

909

8960

(3043238) Trisomy 21 risk [Likelihood] in Fetus

442

6618

0.66

16.71

1.5

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

281

1632

1.73

16.68

1.3

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

160

775

2.07

16.61

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

111

4.05

16.46

2.1

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

281

1643

1.72

16.30

1.4

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

541

3699

1.48

16.14

1.3

35.45

39.60

u/ml

0.10

233

(3020911) Cortisol [Moles/time] in 24 hour Urine

398

2.49

16.01

1.6

1.3

79.27

202.71

nmol/24h

1.29

398

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

5.24

15.98

1.0

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

217

1184

1.84

15.93

1.3

1.4

6.30

6.86

g/l

2.27

154

841

(4062490) Immunoglobulin typing, IgG

214

1163

1.85

15.91

1.3

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

146

698

2.10

15.72

3.4

4.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

315

2.67

15.66

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

659

4704

1.42

15.63

2.9

2.7

1.02

ratio

0.79

583

4159

(3028192) IgG subclass 2 [Mass/volume] in Serum

215

1182

1.83

15.42

1.3

1.4

2.83

3.07

g/l

1.12

153

840

(3024139) IgG subclass 3 [Mass/volume] in Serum

215

1183

1.83

15.38

1.3

1.4

0.37

0.41

g/l

0.88

153

840

(3008898) HLA-B27 [Presence]

773

5691

1.38

15.27

1.1

—

(4034850) Laboratory test

467

3139

1.50

15.18

14.6

7.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

184

968

1.91

15.16

1.5

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

358

2271

1.59

15.13

1.7

11536.30

12376.21

e6/l

0.12

241

1650

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

110

477

2.31

15.08

1.2

1.5

25.50

21.68

u/ml

0.22

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

272

1612

1.70

15.05

1.1

1.52

1.46

g/l

1.52

238

1493

(3025130) Human papilloma virus identified in Specimen

418

2750

1.53

15.04

1.7

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

185

983

1.89

14.80

1.2

55.52

60.64

u/l

0.71

155

874

(3000012) Reticulocyte production index

184

977

1.89

14.75

1.8

2.2

0.83

0.90

1.04

123

630

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

176

923

1.91

14.65

1.1

1.4

—

13.47

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

104

446

2.34

14.64

1.1

3.80

4.32

iu/ml

—

(3045424) Erythrocytes [Presence] in Urine

717

5253

1.38

14.60

2.2

2.0

0.01

0.19

estimate

0.82

258

1993

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

126

587

2.15

14.54

1.8

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

145

715

2.03

14.41

1.1

1.17

1.09

u/l

0.32

278

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

431

2893

1.50

14.13

1.3

57.71

46.57

u/ml

0.51

284

(3017354) Segmented neutrophils/Leukocytes in Blood

168

880

1.92

14.06

2.7

3.5

55.42

56.37

0.24

141

776

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

425

2.33

13.93

1.2

1.3

48.00

100.86

titre

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

127

604

2.11

13.92

1.2

1.5

6.21

6.74

u/l

0.13

104

521

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

123

578

2.13

13.91

1.1

1.2

98.19

82.30

u/l

0.80

101

499

(3044941) Cell count panel - Synovial fluid

266

1604

1.67

13.83

1.5

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

323

2.51

13.41

1.8

3.8

1.15

1.31

0.26

323

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

204

1156

1.77

13.30

1.2

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

143

723

1.98

13.30

1.9

2.1

100.74

98.07

0.38

130

668

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

315

2.51

13.09

3.7

4.0

—

(3000034) Microalbumin [Mass/volume] in Urine

145

745

1.95

12.89

2.9

43.40

66.06

mg/l

0.49

101

538

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

413

2809

1.48

12.73

1.3

6.11

2.88

u/ml

0.34

217

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

260

1597

1.64

12.62

1.2

15.39

18.96

u/ml

0.15

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

162

870

1.87

12.61

1.5

2.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

117

562

2.09

12.55

1.2

23.13

19.18

u/l

0.35

478

(3049717) Cytology report of Urine Cyto stain

380

2553

1.50

12.45

2.0

2.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4164

37519

1.15

12.44

3.8

2.6

0.08

0.10

estimate

0.09

1424

10484

(3037756) Immunofixation for Serum or Plasma

225

1339

1.69

12.35

1.4

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

112

535

2.10

12.20

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

316

2.44

12.04

1.2

29.17

14.54

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.63

11.89

2.0

1.5

40.00

50.54

umol/l

0.84

(44806420) Estimation of glomerular filtration rate

1813

0.46

11.64

2.3

2.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

156

852

1.84

11.56

1.3

1.4

12.15

11.68

umol/l

0.31

140

820

(3022621) pH of Urine by Test strip

1159

9375

1.25

11.49

2.9

2.2

6.23

6.13

3.01

818

5775

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

167

936

1.79

11.38

1.2

1.3

212.00

225.80

titre

0.04

157

(3038515) Glucose [Moles/volume] in Venous blood

237

1462

1.63

11.36

3.6

2.5

7.34

7.33

mmol/l

0.01

230

1429

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

411

2858

1.45

11.34

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

308

2.40

11.25

1.4

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

482

3456

1.40

11.23

1.3

7.62

9.35

u/ml

0.20

527

(3010015) Selenium [Moles/volume] in Serum or Plasma

106

3.49

11.05

1.5

1.8

1.33

1.31

umol/l

0.10

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

405

2823

1.44

11.05

1.3

15.93

21.14

u/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

457

2.12

11.00

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

136

3.16

11.00

1.1

1.3

17.55

78.79

ng/l

2.47

(3002079) Sodium [Moles/time] in 24 hour Urine

107

524

2.04

10.96

1.2

1.3

156.23

163.76

mmol/24h

0.41

107

524

(3019832) Treponema pallidum Ab [Presence] in Serum

2879

25449

1.16

10.94

2.1

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

138

740

1.87

10.87

2.8

2.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

406

2844

1.44

10.79

1.3

1.4

28.81

21.64

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

479

3465

1.39

10.62

1.3

7.24

6.48

u/ml

0.07

357

(4146454) Self-monitoring of blood glucose

140

761

1.84

10.58

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

324

2.32

10.52

2.6

2.8

0.60

0.61

mmol/l

0.30

324

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

385

2689

1.44

10.42

1.4

1.5

146.20

150.18

au/ml

0.24

731

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

262

1695

1.55

10.32

1.2

253.75

338.40

titre

0.21

128

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

249

2.49

10.22

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

457

3307

1.39

10.13

3.0

3.1

1.42

1.35

mg/l

0.97

418

3112

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

324

2203

1.48

10.09

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

333

2.25

9.89

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

347

2404

1.45

9.83

4.4

6.1

591.84

1196.93

iu/ml

0.40

337

(3000093) Morphology [Interpretation] in Blood Narrative

146

823

1.78

9.83

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

129

2265

0.56

9.65

1.5

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

167

987

1.70

9.53

1.2

2.93

2.13

u/ml

0.35

542

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

1078

1.66

9.51

1.2

—

(3005570) Glucose [Moles/volume] in Urine

153

883

1.74

9.51

1.8

1.7

—

45.25

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

175

1048

1.67

9.50

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

234

2.48

9.49

1.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

240

1554

1.55

9.46

1.3

63.25

44.71

u/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

230

2.48

9.33

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

348

2440

1.43

9.27

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

408

2.08

9.26

1.2

4.6

69.05

5832.49

mg/l

3.30

291

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

119

3.11

9.26

2.1

2.7

1.24

1.27

mmol/l

0.02

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1041

1.67

9.24

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

113

601

1.88

9.21

2.1

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1044

1.66

9.14

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

168

1007

1.67

9.11

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

245

3640

0.67

9.04

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

164

2.74

9.04

1.3

1.4

1.17

1.18

mmol/l

0.24

164

(3010838) Calcium [Moles/time] in 24 hour Urine

282

1909

1.48

9.03

1.7

2.0

5.17

5.40

mmol/24h

0.52

255

1760

(3002523) Influenza virus A Ag [Presence] in Specimen

246

3642

0.67

8.92

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

162

968

1.68

8.90

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.69

8.82

1.1

17.40

12.97

nmol/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

195

2.56

8.81

1.1

1.2

—

(3007461) Platelets [#/volume] in Blood

13774

135901

1.35

8.80

35.5

16.5

265.08

257.33

e9/l

38.02

13596

133668

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

237

2.40

8.78

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

511

3859

1.33

8.68

1.1

3.42

4.67

eliau/ml

0.50

661

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

165

998

1.66

8.67

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

125

700

1.79

8.66

2.3

3.0

630.54

946.06

u/ml

1.73

125

692

(3035285) Chloride [Moles/volume] in Venous blood

131

748

1.75

8.51

2.6

1.9

105.09

105.56

mmol/l

0.50

131

739

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

104

554

1.88

8.47

1.6

7.58

6.26

u/l

0.41

462

(3041354) Potassium [Moles/volume] in Venous blood

131

749

1.75

8.47

2.6

1.9

4.00

4.02

mmol/l

0.21

131

740

(40768800) Prostate Pathology biopsy report

1486

0.50

8.44

1.2

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1186

1.59

8.35

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

305

2130

1.44

8.35

1.1

121.23

116.82

1.66

281

1958

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

215

2.42

8.14

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

221

1456

1.52

8.12

2.3

3.2

814.39

187.49

u/ml

0.37

221

1440

(3008757) Leukocyte morphology finding [Identifier] in Blood

136

797

1.71

8.08

2.7

3.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

709

5647

1.27

8.07

1.5

—

(3035941) MCH [Entitic mass]

13774

135979

1.33

8.06

35.3

16.4

30.13

30.14

0.49

13689

135006

(3024731) MCV [Entitic mean volume] in Red Blood Cells

13774

135982

1.33

8.04

35.4

16.5

90.43

90.19

8.93

13689

135007

(3042631) Mycobacterium sp identified in Specimen

155

942

1.65

8.03

2.9

2.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.37

8.02

1.2

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.37

8.02

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

13774

135997

1.33

7.90

36.2

16.8

40.57

41.63

10.04

13689

134957

(3026361) Erythrocytes [#/volume] in Blood

13774

136009

1.33

7.79

35.4

16.5

4.52

4.58

e12/l

31.37

13561

133526

(1002224) Polysomnography panel

882

7229

1.23

7.79

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

362

2.04

7.74

1.2

—

(3004451) EKG impression Narrative

370

2.03

7.67

1.2

—

(3010813) Leukocytes [#/volume] in Blood

13775

136037

1.32

7.63

35.6

16.5

7.12

6.61

e9/l

134.67

13570

133510

(3023199) Leukocytes [#/volume] in Pleural fluid

123

714

1.72

7.59

1.5

1.4

14838.53

3842.54

e6/l

0.70

488

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

315

2253

1.40

7.59

1.3

4.64

4.07

u/ml

0.27

156

1098

(3024263) Appearance of Synovial fluid

441

1.93

7.55

1.7

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

146

2.67

7.50

1.4

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

199

2.41

7.50

1.0

1.1

—

(4195642) Thrombophilia screening test

302

2153

1.41

7.42

1.2

—

(3020491) Glucose [Moles/volume] in Blood

140

847

1.66

7.42

2.4

1.6

7.12

6.07

mmol/l

2.31

107

657

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.06

7.37

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

142

864

1.65

7.37

1.6

2.1

21.26

22.97

ug/l

0.31

137

853

(3045788) Cell count panel - Pleural fluid

107

603

1.78

7.33

1.5

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

131

2.75

7.32

1.3

67.50

62.10

ug/l

0.52

131

(3000963) Hemoglobin [Mass/volume] in Blood

13774

136063

1.31

7.30

35.8

16.6

135.34

137.22

g/l

49.95

13689

135095

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

208

2.35

7.28

1.3

1.8

—

1.19

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

149

923

1.62

7.21

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

326

2369

1.38

7.17

1.3

3.28

3.80

u/ml

0.32

130

943

(3044927) Protein electrophoresis panel - Urine

102

574

1.78

7.04

1.1

—

(3000492) Spirometry study

1589

13854

1.16

7.04

1.5

1.4

—

21.97

—

(3003434) Protein [Mass/volume] in Pleural fluid

133

807

1.65

7.00

1.4

263.12

35.26

g/l

0.50

121

743

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

439

1.89

6.99

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

433

1.89

6.94

1.4

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.48

6.94

1.2

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

448

1.88

6.90

1.3

1.2

109.13

107.80

0.20

409

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

5.42

6.88

1.0

1.3

1.31

1.21

u/field

0.21

(3024891) Influenza virus A+B Ag [Presence] in Specimen

490

3807

1.29

6.86

1.2

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

640

0.33

6.81

1.1

1.3

75.43

68.35

ug/l

0.28

640

(3006270) Folate [Moles/volume] in Blood

112

656

1.71

6.75

1.1

353.04

406.62

nmol/l

2.00

613

(3036782) Glucose [Moles/volume] in Pleural fluid

116

686

1.69

6.75

1.2

1.3

6.58

6.09

mmol/l

0.82

102

645

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

117

696

1.68

6.66

2.2

2.7

0.79

0.70

e9/l

1.22

110

680

(3013727) Leukocytes other/Leukocytes in Blood

244

2.17

6.55

2.0

3.4

56.34

49.32

1.59

233

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.94

6.49

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

103

599

1.72

6.39

1.9

2.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

446

1.84

6.37

1.1

39.48

277.21

ng/l

0.91

140

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

228

1592

1.44

6.36

1.2

1.1

96.64

96.24

0.08

215

1512

(3020876) Protein [Mass/time] in 24 hour Urine

157

1017

1.55

6.34

2.4

2.7

1.48

1.41

g/24h

0.11

636

(40761995) Spermatozoa Progressive [#/volume] in Semen

570

0.31

6.32

3.0

3.4

33.28

44.82

2.36

570

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

569

0.31

6.30

6.0

6.8

11.44

8.74

1.54

569

(3028308) Erythrocytes [#/volume] in Pleural fluid

105

617

1.70

6.28

1.6

1.4

25533.46

55550.95

e6/l

1.03

327

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

464

1.81

6.22

1.9

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

819

6824

1.21

6.19

1.4

1.3

210.45

224.85

miu/ml

0.43

250

3569

(3030313) Adrenal Ab [Titer] in Serum

150

2.46

6.13

1.1

—

32.00

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

489

1.78

6.10

1.3

1.2

0.31

0.29

g/l

1.47

400

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

282

2.02

5.89

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

127

801

1.59

5.80

1.1

—

0.26

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

130

825

1.58

5.78

1.4

1.5

35420.45

103964.90

e6/l

2.11

547

(3033705) Calcium.ionized [Moles/volume] in Venous blood

118

732

1.61

5.77

2.7

1.9

1.20

mmol/l

0.07

118

723

(3033923) Metanephrine [Moles/time] in 24 hour Urine

155

2.38

5.73

1.1

0.89

1.10

umol/24h

0.22

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.90

5.68

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

575

1.69

5.67

1.1

5.99

13.48

u/ml

1.52

(3001556) Androgen free Index in Serum or Plasma

182

2.25

5.58

1.6

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

9.98

5.51

1.4

3.4

—

(3052592) Norovirus Ag [Presence] in Stool

122

2.54

5.49

1.6

1.4

—

(3028433) Virus identified in Specimen by Culture

304

1.94

5.46

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

275

0.22

5.46

1.0

1.1

1.67

1.16

mom

—

275

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

191

2.20

5.41

1.0

76.17

78.74

ug/l

0.15

156

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

509

1.71

5.36

1.8

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

286

1.96

5.33

1.3

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

510

1.71

5.32

1.2

1.1

90.75

81.78

u/l

0.25

460

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

153

1029

1.49

5.26

1.2

85.65

80.53

0.70

(3004775) Volume in Urine collected for unspecified duration

100

611

1.64

5.24

2.0

2.5

730.01

656.65

0.74

458

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

796

0.47

5.21

1.2

9.58

8.87

mm/h

0.21

796

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

102

628

1.62

5.19

2.4

2.8

41.69

41.71

0.00

332

(3027456) Digoxin [Moles/volume] in Serum or Plasma

132

864

1.53

5.17

3.1

3.0

0.76

0.81

nmol/l

0.68

109

682

(3032057) Clostridioides difficile [Presence] in Stool

114

2.54

5.16

2.2

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

395

3110

1.27

5.09

2.1

2.2

11.80

10.97

mg/l

1.55

370

2951

(3016750) Collection duration of Urine

457

1.73

5.09

1.8

2.5

530.79

495.44

min

2.94

376

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

466

1.72

5.03

1.8

1.5

2.06

2.82

u/field

0.49

340

(1761482) Bacteria [#/volume] in Urine by Culture

242

1784

1.36

5.01

3.9

3.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

506

1.68

4.95

1.2

1.1

32.75

20.53

u/l

0.37

457

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

492

1.69

4.91

1.9

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

163

1128

1.45

4.88

1.2

38.63

48.49

u/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

106

670

1.58

4.87

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

136

2.35

4.85

2.9

2.2

8.24

8.12

mmol/l

0.04

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.91

4.84

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.91

4.84

1.3

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

117

758

1.54

4.83

2.1

2.6

559.54

522.48

e6/l

0.57

596

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

379

1.77

4.69

1.2

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

379

1.77

4.69

1.2

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

104

663

1.57

4.63

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.67

4.54

2.5

1.9

0.74

0.81

u/field

0.15

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

444

3598

1.24

4.51

1.2

4.76

4.18

0.54

735

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.16

4.49

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

238

1.93

4.29

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.58

4.27

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

158

2.15

4.23

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

185

2.05

4.20

2.3

2.9

19.06

38.10

mg/l

1.81

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

108

2.40

4.18

1.7

—

(3006245) CD3-CD19+ cells/cells in Blood

484

1.63

4.18

1.8

2.3

9.89

8.66

0.43

457

(3002256) Pathology report gross observation

1651

14937

1.12

4.14

1.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

111

738

1.50

4.13

1.4

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

277

1.84

4.12

1.2

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.98

4.09

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

307

1.79

4.08

1.8

1.6

9.10

8.68

ug/l

0.35

307

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

396

1.69

4.08

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

236

1.90

4.05

1.4

1.3

55.34

48.13

0.54

211

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

229

1.92

4.05

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

310

3886

0.79

4.03

1.4

1.3

2.96

3.40

ug/l

1.70

288

3622

(4268621) Lupus anticoagulant assay

223

1684

1.33

4.02

2.5

2.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

406

1.67

3.99

1.6

1.2

0.29

0.22

g/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

961

8429

1.15

3.98

3.2

4.6

10.91

28.78

ug/l

2.52

764

6481

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.93

3.98

1.1

1.0

7.41

12.28

u/l

0.46

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

560

0.46

3.96

1.2

1.1

38.99

62.56

u/ml

1.54

552

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

474

1.60

3.78

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

474

1.60

3.78

1.8

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

474

1.60

3.78

1.8

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

475

1.60

3.76

1.8

2.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.18

3.75

6.6

9.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

147

1053

1.40

3.74

2.2

3.4

3.44

9.50

nmol/l

0.60

138

1018

(37208534) Antinuclear antibody arbitrary concentration in serum

376

1.67

3.73

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

2.31

3.72

1.0

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.90

3.71

1.1

1.4

0.81

0.76

umol/24h

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

167

2.03

3.71

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1382

0.67

3.70

1.3

1.8

372.83

1286.58

pmol/l

—

159

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

431

1.62

3.68

1.2

1.3

19.19

13.99

u/l

0.38

398

(3003694) ABO and Rh group [Type] in Blood

4073

42755

0.93

3.68

1.6

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.78

3.66

1.1

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

424

1.63

3.66

1.0

1.1

1.58

4.07

u/ml

1.04

247

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

915

0.60

3.63

2.1

1.8

1.30

2.44

u/ml

1.53

272

(46235168) Fasting glucose [Moles/volume] in Blood

194

0.26

3.51

1.2

1.1

—

6.39

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

115

799

1.44

3.50

2.3

2.8

221.55

231.22

e6/l

0.23

660

(40768441) Liver Pathology biopsy report

117

816

1.43

3.49

1.5

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

541

1.53

3.46

2.0

2.7

21.50

223.68

ug/l

1.05

516

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

381

3136

1.22

3.43

2.7

4.1

920.88

2144.98

u/ml

0.59

312

2747

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

131

936

1.40

3.42

1.2

1.07

1.06

ratio

0.63

110

793

(3029396) Erythrocyte agglutination [Presence] in Blood

837

0.59

3.41

3.0

3.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

116

1626

0.71

3.39

1.3

1.5

26.74

35.39

nmol/l

2.76

1527

(3046861) Legionella sp Ag [Presence] in Urine

2.97

3.39

1.4

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

129

921

1.40

3.39

1.3

1.2

39.14

61.23

u/ml

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

305

1.70

3.32

1.1

1.0

0.64

1.65

u/ml

0.62

266

(3005011) Chlamydia sp Ab [Titer] in Serum

154

2.01

3.31

1.7

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

668

1.47

3.31

2.1

1.9

130.02

134.13

0.20

637

(3004616) Nuclear Ab [Presence] in Serum

187

1422

1.32

3.29

1.4

1.3

—

(3011412) CD3 cells [#/volume] in Blood

144

1058

1.36

3.20

2.2

2.5

1423.78

1215.28

e6/l

2.62

123

913

(3016330) Potassium [Moles/time] in 24 hour Urine

150

2.00

3.16

1.2

1.3

—

73.69

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

192

1.87

3.16

1.2

10.10

11.74

pmol/l

0.18

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.53

3.10

1.1

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

373

1.61

3.10

1.5

2.0

0.20

0.25

e9/l

0.28

145

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.42

3.09

1.1

1.0

247.75

260.02

nmol/l

0.12

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

630

1.46

3.07

1.1

100.82

94.19

1.34

519

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

145

2.00

3.07

1.0

2.46

0.79

u/ml

0.33

107

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

445

1.55

3.06

1.1

99.27

94.03

0.73

210

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

454

1.54

3.03

1.2

117.37

111.19

0.58

408

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

211

1652

1.28

3.02

1.3

1.5

9.43

7.31

mmol/l

9.14

202

1598

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

106

2.17

3.00

1.0

1.1

0.03

0.05

u/ml

0.52

106

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

330

1.63

2.99

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

330

1.63

2.99

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

552

1.48

2.99

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

2.94

0.0

3.7

—

0.00

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.23

2.94

1.7

1.6

0.95

1.55

mg/l

0.37

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.23

2.94

1.7

1.6

1.25

2.46

mg/l

0.94

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.23

2.94

1.7

1.6

3.28

2.96

mg/l

0.08

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.23

2.94

1.7

1.6

3.60

1.66

mg/l

0.53

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.23

2.94

1.7

1.6

1.92

2.28

mg/l

0.10

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.23

2.94

1.7

1.6

2.01

4.71

mg/l

1.44

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

631

1.44

2.87

2.1

1.8

1.90

1.71

u/field

0.20

361

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

161

1226

1.31

2.86

3.3

5.6

54.99

107.09

u/ml

1.30

462

(3003329) Lymphocytes/Leukocytes in Synovial fluid

117

850

1.38

2.84

1.5

34.15

37.22

0.34

522

(3017817) Protein [Mass] in Urine collected for unspecified duration

112

811

1.38

2.78

2.5

3.1

1790.75

1243.41

0.90

112

804

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

803

1.38

2.77

1.9

2.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

811

0.64

2.71

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

511

5868

0.86

2.71

1.6

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.59

2.68

1.0

1.1

—

(3012565) Volume of 24 hour Urine

476

1.49

2.68

1.7

2.3

2293.82

2072.09

0.74

443

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

125

2.00

2.68

13.5

11.4

6.41

5.28

mmol/l

0.43

125

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

279

0.39

2.64

1.1

1.0

13.67

8.41

u/ml

0.29

279

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

106

2.07

2.60

1.0

1.3

58.90

57.74

—

(3035880) pH of Pleural fluid

329

1.58

2.56

1.2

1.3

7.27

7.41

1.99

224

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

588

1.43

2.56

10.1

6.3

1947.12

7249.48

u/ml

0.38

100

(3006567) Chloride [Moles/time] in 24 hour Urine

5.44

2.53

1.0

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

149

1.88

2.53

1.4

1.5

37.94

20.53

2.01

136

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

200

1.75

2.52

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

434

1.50

2.52

1.2

105.04

95.29

0.89

208

(3026692) Albumin [Mass/volume] in Peritoneal fluid

193

1.76

2.51

1.5

1.3

11.86

14.12

g/l

0.57

144

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.37

2.46

2.0

1.9

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.10

2.46

1.0

0.03

0.12

u/ml

1.22

(3018001) Oat IgE Ab [Units/volume] in Serum

130

1.92

2.43

1.1

0.30

1.06

u/ml

0.44

(3043410) Blood group antigens tested for on Red Blood Cells

280

1.61

2.39

2.1

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1139

0.72

2.39

1.0

0.74

0.75

u/ml

0.01

226

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.06

2.35

1.0

0.38

3.33

u/ml

1.17

(3003888) Timothy IgE Ab [Units/volume] in Serum

397

3412

1.17

2.32

1.1

4.47

5.77

u/ml

1.13

231

1838

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

119

1.93

2.28

1.2

1.1

2.51

2.04

iu/ml

0.45

(3051387) C reactive protein [Mass/volume] in Capillary blood

262

2179

1.20

2.25

4.4

2.9

20.26

25.61

mg/l

2.49

180

1459

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

185

1.73

2.25

1.3

862.61

315.62

pmol/l

0.55

141

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

208

1.68

2.23

1.1

0.12

0.02

u/ml

0.52

131

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

193

1.71

2.23

1.4

1.2

84.63

122.91

mg/l

0.15

134

(3042111) Morphology [Interpretation] in Bone marrow Narrative

169

1344

1.26

2.23

1.5

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2054

21726

0.93

2.22

3.8

3.7

21.44

21.78

0.35

744

8769

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

240

1.62

2.19

1.1

—

(1175426) CD3 cells/Lymphocytes in Blood

115

873

1.32

2.18

1.8

2.1

77.18

73.73

2.30

110

847

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

243

2016

1.21

2.16

1.1

2.03

2.90

0.70

470

(3011841) English Walnut IgE Ab [Units/volume] in Serum

144

1.80

2.12

1.0

0.26

1.02

u/ml

0.47

108

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

307

1.53

2.07

2.2

82.45

57.60

ug/l

0.47

302

(4015189) Microbial culture of sputum

153

1.76

2.05

2.6

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

448

3927

1.14

2.04

1.2

1.1

1.31

2.45

u/ml

4.08

266

2015

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

191

1.67

2.04

3.3

3.2

4.31

180.92

ug/l

0.63

191

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

176

1.70

2.03

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1259

0.76

1.98

1.1

8.04

19.03

u/ml

5.66

588

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

170

1.70

1.97

1.0

1.1

0.43

11.97

u/ml

0.51

(3042010) Triglyceride [Moles/volume] in Pleural fluid

112

1.87

1.94

1.0

1.3

0.48

2.11

mmol/l

—

(3020393) Adenovirus Ag [Presence] in Stool

2.02

1.94

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

127

1.81

1.92

1.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.97

1.83

2.1

3.2

12.14

50.21

pmol/l

—

(4212803) Bone marrow aspirate examination

2.20

1.82

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

113

882

1.28

1.80

1.3

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.12

1.80

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

369

3225

1.15

1.79

1.9

2.3

5.31

5.53

umol/l

0.13

272

2380

(3014891) Appearance of Pleural fluid

2.26

1.79

1.8

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

372

3254

1.14

1.79

1.1

0.81

1.02

u/ml

0.51

178

1407

(3017704) Immunofixation for Urine

344

1.45

1.77

1.1

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

116

1.81

1.76

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

737

1.30

1.75

1.7

2.3

—

(44806071) Cardiolipin IgM antibody measurement

208

1.58

1.74

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.66

1.71

2.0

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

170

1.64

1.71

1.2

1.4

102.80

57.84

mu/l

0.56

137

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

322

1.46

1.71

2.1

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

322

1.46

1.71

2.1

2.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

116

917

1.26

1.69

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

306

2655

1.15

1.67

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

119

946

1.26

1.66

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

156

1278

1.22

1.66

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1011

0.76

1.65

1.2

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.15

1.65

1.0

0.02

0.45

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

498

4463

1.12

1.65

1.6

26.99

5.57

iu/ml

0.36

755

(40757373) Influenza virus identified in Isolate

149

1.67

1.64

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

325

1.44

1.64

2.1

2.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

284

1.48

1.64

1.1

1.2

67.43

82.72

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

268

1.49

1.63

2.3

1.9

358.15

4309.01

e6/l

0.67

169

(3041918) Cholesterol [Moles/volume] in Pleural fluid

135

1.70

1.60

1.0

1.2

2.18

1.91

mmol/l

0.30

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.06

1.58

1.0

1.3

44.43

32.53

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.99

1.57

1.0

2.67

3.30

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1193

0.78

1.57

1.0

2.79

2.15

u/ml

0.10

250

(40768806) Pleura Pathology biopsy report

637

1.30

1.55

1.6

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.84

1.54

1.3

1.1

0.67

0.75

iu/ml

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.88

1.53

4.4

3.1

19.84

10.49

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.97

1.52

1.4

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

232

1.51

1.52

1.3

37.39

45.20

0.54

165

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.22

1.45

4.4

4.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

284

1.44

1.45

1.2

66.00

71.32

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

293

1.43

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.12

1.43

1.0

3060.00

2778.38

titre

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

377

1.38

1.43

1.7

2015.13

13638.20

u/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

286

1.43

1.40

1.1

4.40

2.14

u/ml

0.49

179

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

894

0.77

1.39

1.2

1.3

690.91

1074.46

titre

1.42

184

(3024316) Viscosity of Plasma

2.17

1.39

1.0

2.0

1.66

1.41

mpas

—

(40762887) Creatinine [Moles/volume] in Blood

2.07

1.37

1.4

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

11139

110059

1.04

1.37

31.1

13.2

332.45

333.41

g/l

22.58

11083

109430

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

364

1.37

1.36

2.4

2.1

87.06

94.60

ug/min

0.04

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

105

1.71

1.31

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

105

1.71

1.31

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

128

1.64

1.31

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.09

1.29

1.6

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

317

1.39

1.28

3.1

3.4

1.71

1.97

ratio

0.80

293

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

145

1.58

1.27

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

185

1.51

1.27

1.0

0.03

0.22

u/ml

1.45

105

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.78

1.26

1.2

0.16

0.57

u/ml

—

(3033099) Centromere Ab [Titer] in Serum

286

1.40

1.23

1.1

—

(3044007) Cell count panel - Peritoneal fluid

237

1.43

1.20

2.2

1.9

—

(4281824) Cell count and differential, peritoneal fluid

1170

0.82

1.19

1.1

—

(3013762) Body weight Measured

2.10

1.18

1.1

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

189

1.48

1.17

1.4

1.7

0.41

0.39

ug/l

0.13

149

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.70

1.16

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

519

0.73

1.15

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.49

1.15

1.2

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.49

1.15

1.0

1.3

1.68

1.45

mg/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

694

1.24

1.14

1.2

3.36

15.82

u/ml

1.48

(3050794) Legionella sp Ab [Presence] in Serum

1.68

1.12

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

151

1.52

1.10

1.2

2.0

6.46

434821.36

nmol/l

1.68

135

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.75

1.05

2.8

6.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.95

1.03

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

620

0.77

1.02

1.5

1.6

1965.71

2669.13

titre

—

103

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

229

1.39

1.02

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

761

0.80

0.98

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

139

1.51

0.98

1.0

0.75

0.95

u/ml

0.09

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.17

0.97

1.0

2.7

0.91

2.03

mu/l

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.94

0.96

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

467

0.75

0.95

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

366

3345

1.09

0.94

1.1

1.30

1.95

u/ml

1.49

224

1598

(3022689) Creatine [Moles/volume] in Urine

389

1.28

0.94

1.2

1.4

7.28

9.29

mmol/l

2.64

389

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

233

1.37

0.94

2.4

1.8

4187.41

16388.13

e6/l

0.61

103

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

374

0.72

0.93

1.0

1.1

20.91

31.89

iu/ml

1.21

374

(40765089) Chromosome analysis panel - Blood by G-banded

788

0.81

0.93

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

443

1.26

0.93

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

101

1.58

0.92

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.66

0.90

1.3

1.0

0.08

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

195

1729

1.13

0.90

2.8

4.0

744.30

536.41

u/ml

0.23

173

1582

(4094501) Cardiovascular stress test using bicycle ergometer

278

3052

0.91

0.89

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

185

1.40

0.88

1.3

—

2254.21

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

657

0.80

0.84

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

504

1.23

0.84

2.8

2.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

733

1.19

0.82

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2768

26906

1.03

0.82

4.1

4.5

1.98

2.18

ug/l

0.27

2485

25017

(3036670) Protein [Mass/volume] in Synovial fluid

231

1.34

0.81

1.2

1.3

37.15

39.93

g/l

0.76

124

(3014148) Varicella zoster virus Ab [Titer] in Serum

218

2408

0.90

0.81

1.2

—

(3020650) Glucose [Presence] in Urine

553

0.79

0.80

1.7

1.4

0.00

0.04

estimate

2.34

553

(3041806) Other cells [#/volume] in Blood by Manual count

108

930

1.16

0.79

1.5

1.4

0.51

0.52

e9/l

0.15

108

930

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.72

0.79

1.1

—

4.35

—

(40768446) Kidney Pathology biopsy report

472

1.23

0.79

2.0

1.7

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.78

0.0

1.2

—

0.38

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.78

0.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.58

0.77

1.2

1.1

1.92

1.89

umol/24h

0.04

(4133840) Spirometry

392

0.76

0.75

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.69

0.75

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.69

0.75

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.60

0.74

1.8

1.4

357.08

301.87

umol/24h

0.41

(3033086) Enterovirus Ab [Titer] in Serum

1.84

0.73

1.0

1.1

—

(21494434) Karyotype in Bone marrow

743

1.17

0.72

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

264

0.72

0.71

1.2

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

213

2335

0.91

0.71

1.1

2.20

3.11

eliau/ml

1.41

1318

(3016135) IgD [Mass/volume] in Serum

1.92

0.70

1.2

1.1

30.20

46.95

mg/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

318

1.26

0.69

1.4

—

(4211845) Urine protein measurement

554

1.19

0.68

2.8

2.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

1.45

0.67

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

128

1135

1.13

0.65

1.5

1.6

52.76

52.31

0.04

727

(3019174) dRVVT (LA screen)

128

1.40

0.64

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.47

0.63

1.0

1.1

0.12

16.99

u/ml

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.63

0.62

1.6

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

572

1.17

0.59

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

287

0.76

0.58

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.44

0.58

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

300

1.23

0.57

1.1

1.2

—

420.87

—

(3032868) Hemoglobin electrophoresis panel in Blood

167

1.31

0.55

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.50

0.55

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.50

0.55

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

211

2279

0.92

0.55

1.4

7.17

6.71

mmol/l

1.85

196

2054

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

150

1.33

0.55

1.2

1.3

62.06

235.68

ug/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.58

0.54

1.8

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.58

0.54

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

133

1.35

0.54

1.1

1.0

0.09

0.35

u/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

147

0.68

0.54

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.48

0.52

1.0

1.4

0.13

0.17

umol/l

1.91

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

779

0.87

0.52

6.1

7.7

14.38

63.51

ug/l

1.41

532

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

169

1.30

0.52

8.0

7.2

10.54

10.79

0.15

169

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.43

0.52

1.0

1.1

0.01

1.91

u/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

306

2867

1.07

0.51

1.8

1.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

292

0.79

0.51

3.3

2.9

92.22

103.36

ng/l

—

163

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

250

1.24

0.51

2.5

2.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

108

1198

0.90

0.51

1.0

5.57

1.85

u/ml

0.34

311

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

145

0.69

0.51

1.0

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

109

1.37

0.50

1.0

1.1

0.10

22.33

u/ml

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.52

0.48

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.49

0.47

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.43

0.45

1.3

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

238

2225

1.07

0.45

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

174

1.26

0.44

1.0

1.38

0.67

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

184

1.25

0.42

1.0

0.15

0.07

u/ml

0.25

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.56

0.42

1.6

1.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

21.00

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.39

0.40

1.1

—

0.40

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

633

1.12

0.39

1.1

1.0

6.60

11.60

u/ml

1.92

435

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

118

1081

1.09

0.39

1.1

12.87

7.11

iu/ml

0.90

362

(3001729) Color of Synovial fluid

1.31

0.39

1.1

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.39

0.38

1.0

1.1

—

(3022670) pH of Venous cord blood

1.39

0.38

1.2

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

187

1.23

0.38

1.0

0.92

0.26

u/ml

0.46

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

608

0.89

0.37

2.4

2.2

7.69

9.59

mg/l

2.03

513

(4038314) Semen analysis, post vasectomy

157

0.76

0.36

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.26

0.36

1.8

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.43

0.35

2.8

4.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.33

0.35

1.0

—

(3042733) HLA Ab [Presence] in Serum

403

1.14

0.35

5.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

109

1.28

0.33

1.1

89.14

96.00

titre

0.12

109

(4035726) Immunohistochemistry procedure

831

8506

0.97

0.32

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

313

1.15

0.31

1.1

1.2

—

30.81

u/ml

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

129

1.24

0.29

2.4

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

323

0.86

0.29

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

323

0.86

0.29

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

323

0.86

0.29

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

148

1.21

0.28

1.4

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

205

1.17

0.26

1.1

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

446

0.89

0.26

1.7

90.95

138.62

au/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

178

1.18

0.25

2.6

—

(3045142) Bone marrow Pathology biopsy report

107

1002

1.07

0.25

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.18

0.24

1.2

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

142

1.19

0.24

1.4

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

294

2831

1.04

0.24

1.1

6.13

4.55

u/ml

0.76

155

1273

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

694

6772

1.02

0.23

2.5

3.0

71.59

41.77

u/ml

0.31

668

6572

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

273

2626

1.04

0.23

1.1

24.24

14.24

au/ml

0.85

900

(3034426) Prothrombin time (PT)

455

1.10

0.23

1.2

28.62

28.12

0.34

455

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

2.99

2.69

u/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

0.04

0.25

u/ml

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.22

0.22

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

657

0.93

0.21

1.2

1.8

181.11

193.34

u/l

1.26

652

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

0.02

—

(3006598) pH of Arterial cord blood

1.19

0.21

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

343

1.11

0.21

2.2

2.3

3.95

2.43

ug/l

0.30

293

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

166

0.84

0.21

3.2

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

109

1147

0.95

0.20

1.3

157.47

178.09

pmol/l

0.78

109

1147

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.20

0.0

1.2

—

36.64

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.21

0.19

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.15

0.19

12.0

9.2

130.00

320.40

e6/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

231

1.12

0.19

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

577

1.07

0.19

2.0

2.6

84.33

137.48

au/ml

1.16

(3002331) Protein [Mass/volume] in Peritoneal fluid

165

1.15

0.18

1.5

1.4

33.38

25.91

g/l

1.34

124

(3010375) cycloSPORINE [Mass/volume] in Blood

486

0.92

0.18

24.5

28.0

120.58

120.50

ug/l

0.00

403

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

185

1.13

0.17

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

152

0.85

0.17

1.7

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

225

1.11

0.15

15.2

7.5

5.73

5.68

kpa

0.05

225

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

129

0.85

0.15

1.0

1.1

9.16

8.25

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.79

0.14

1.1

1.3

—

(40765096) Chromosome analysis panel by Banding

258

1.08

0.12

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

114

1.14

0.11

1.2

1.5

—

(3047189) Immunofixation for 24 hour Urine

342

0.93

0.11

1.5

1.9

—

(40768795) Lymph node Pathology biopsy report

103

1063

0.97

0.11

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

197

2006

0.98

0.09

2.5

2.6

31.25

28.70

iu/ml

0.10

149

(3051101) Glucose [Moles/volume] in Cord blood

124

0.88

0.09

3.3

6.0

9.06

8.35

mmol/l

0.34

124

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

257

2523

1.02

0.08

1.1

0.30

u/ml

0.00

107

687

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.81

0.07

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.82

0.07

1.0

1.1

0.42

4.34

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

756

0.98

0.05

1.6

1.8

3.48

3.41

mg/l

0.06

732

(3025018) Bordetella pertussis Ab [Titer] in Serum

107

1048

1.02

0.05

1.2

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

140

1.07

0.04

2.3

1.91

3.21

mg/l

3.01

135

(3038177) Helicobacter pylori Ab [Presence] in Serum

249

2506

0.99

0.04

1.3

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

893

1.02

0.03

1.1

1706.25

1423.26

miu/ml

1.75

893

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

128

1291

0.99

0.03

1.8

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

308

3090

0.99

0.02

1.5

105.56

107.46

pmol/l

0.02

301

3007

(3034891) Synovial lining cells/cells in Synovial fluid

459

1.02

0.02

1.4

1.5

2.00

4.23

—

101

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

268

0.97

0.02

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

268

0.97

0.02

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

268

0.97

0.02

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

268

0.97

0.02

1.2

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

132

1.06

0.02

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

243

2437

0.99

0.02

1.1

—

3.26

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

212

1.04

0.01

1.5

1.4

6.20

5.52

mmol/l

2.77

212

(3014133) Dog dander IgE Ab [Units/volume] in Serum

304

3020

1.00

0.01

1.1

2.94

3.78

u/ml

0.60

178

1508

(3024471) HLA-A [Type]

382

1.02

0.01

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

196

0.97

0.01

2.0

2.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

443

1.01

0.00

2.1

30.73

30.74

0.00

443

(3007916) DNA double strand Ab [Titer] in Serum

134

0.97

0.00

1.1

1.4

—

249.46

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

157

1.02

0.00

1.1

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

226

1.02

0.00

2.4

1.8

2.61

3.40

ug/l

0.26

143

(3026470) Cobalt [Mass/volume] in Blood

356

1.01

0.00

2.1

2.3

6.87

3.36

ug/l

0.38

340

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

659

1.00

0.00

2.9

3.3

7.79

9.07

mg/l

0.91

533

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

178

1.01

0.00

4.1

5.7

44.36

40.42

ug/min

0.06

123

(3032352) Blasts [#/volume] in Cerebral spinal fluid

116

1.03

0.00

1.2

2.2

—

(3024932) HLA-DR beta [Type]

376

1.01

0.00

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

291

0.99

0.00

1.2

1.8

38.00

40.64

g/l

1.35

291

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

-0.00

0.0

20.2

—

6.08

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.4

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.5

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.8

—

18.33

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

5.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3037201) Protein S Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

74.17

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

29.26

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.94

—

Mortality – FinRegistry

↥

Association

Association between endpoint KRA_PSY_PERSON_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
KRA_PSY_PERSON_EXMORE	2.976 [2.71, 3.27]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.038

During the follow-up period (1.1.1998 — 31.12.2019), 3469 out of 43099 females with KRA_PSY_PERSON_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
KRA_PSY_PERSON_EXMORE	3.456 [3.19, 3.75]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 4951 out of 31178 males with KRA_PSY_PERSON_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have KRA_PSY_PERSON_EXMORE.

N-year risk	Females	Males
1	0.219%	0.631%
5	1.401%	3.727%
10	3.86%	8.675%
15	7.525%	16.361%
20	12.905%	26.29%

Relationships between endpoints

↥

Index endpoint: KRA_PSY_PERSON_EXMORE – Personality disorders, excluding more controls

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Personality disorders, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints